Nordson (NDSN) 10-Q 24 Aug 23 2023 Q3 Quarterly report Financial data

Cover Page

Cover Page - shares	9 Months Ended
	Jul. 31, 2023	Aug. 22, 2023
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jul. 31, 2023
Document Transition Report	false
Entity File Number	0-7977
Entity Registrant Name	NORDSON CORPORATION
Entity Incorporation, State or Country Code	OH
Entity Tax Identification Number	34-0590250
Entity Address, Address Line One	28601 Clemens Road
Entity Address, City or Town	Westlake
Entity Address, State or Province	OH
Entity Address, Postal Zip Code	44145
City Area Code	440
Local Phone Number	892-1580
Title of 12(b) Security	Common Shares, without par value
Trading Symbol	NDSN
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding (in shares)		57,014,497
Amendment Flag	false
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q3
Entity Central Index Key	0000072331
Current Fiscal Year End Date	--10-31

Condensed Consolidated Statemen

Condensed Consolidated Statements of Income - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Income Statement [Abstract]
Sales	$ 648,677	$ 662,128	$ 1,909,319	$ 1,906,697
Operating costs and expenses:
Cost of sales	288,357	296,544	868,007	843,344
Selling and administrative expenses	189,324	180,666	553,590	538,602
Total operating costs and expenses	477,681	477,210	1,421,597	1,381,946
Operating profit	170,996	184,918	487,722	524,751
Other income (expense):
Interest expense	(12,089)	(5,737)	(32,532)	(16,748)
Interest and investment income	603	572	1,628	1,456
Other income (expense)- net	2,542	752	(2,059)	(37,720)
Total other income (expense)	(8,944)	(4,413)	(32,963)	(53,012)
Income before income taxes	162,052	180,505	454,759	471,739
Income taxes	34,161	38,694	95,044	99,885
Net income	$ 127,891	$ 141,811	$ 359,715	$ 371,854
Average common shares (in shares)	56,989	57,409	57,114	57,782
Incremental common shares attributable to equity compensation (in shares)	541	560	543	610
Average common shares attributable and common share equivalents (in shares)	57,530	57,969	57,657	58,392
Basic earnings per share (in dollars per share)	$ 2.24	$ 2.47	$ 6.30	$ 6.44
Diluted earnings per share (in dollars per share)	$ 2.22	$ 2.45	$ 6.24	$ 6.37

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Statement of Comprehensive Income [Abstract]
Net income	$ 127,891	$ 141,811	$ 359,715	$ 371,854
Components of other comprehensive income (loss):
Foreign currency translation adjustments	3,455	(21,220)	79,986	(81,479)
Pension and other postretirement plan adjustments, net of tax	(159)	1,848	(908)	7,686
Total other comprehensive income (loss)	3,296	(19,372)	79,078	(41,746)
Total comprehensive income	$ 131,187	$ 122,439	$ 438,793	$ 330,108

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Jul. 31, 2023	Oct. 31, 2022
Current assets:
Cash and cash equivalents	$ 143,138	$ 163,457
Receivables - net	533,793	537,313
Inventories - net	439,741	383,398
Prepaid expenses and other current assets	60,249	48,803
Total current assets	1,176,921	1,132,971
Goodwill	2,110,780	1,804,693
Intangible assets - net	350,524	329,402
Property, plant and equipment - net	350,735	353,442
Operating right of use lease assets	104,592	102,279
Deferred income taxes	12,199	10,447
Other assets	91,281	87,141
Total assets	4,197,032	3,820,375
Current liabilities:
Current maturities of long-term debt and notes payable	110,643	392,537
Accrued liabilities	169,635	206,828
Accounts payable	105,075	99,276
Customer advanced payments	95,274	92,584
Income taxes payable	26,661	22,333
Operating lease liability - current	16,809	15,738
Finance lease liability - current	4,512	4,907
Total current liabilities	528,609	834,203
Long-term debt	727,455	345,320
Operating lease liability - noncurrent	91,287	90,768
Deferred income taxes	119,734	110,781
Postretirement obligations	57,528	56,804
Pension obligations	46,782	40,551
Finance lease liability - noncurrent	10,507	11,184
Other long-term liabilities	35,324	36,389
Shareholders' equity:
Common shares	12,253	12,253
Capital in excess of stated value	660,218	626,697
Retained earnings	3,900,384	3,652,216
Accumulated other comprehensive loss	(128,704)	(207,782)
Common shares in treasury, at cost	(1,864,345)	(1,789,009)
Total shareholders' equity	2,579,806	2,294,375
Total liabilities and shareholders' equity	$ 4,197,032	$ 3,820,375

Consolidated Statements of Shar

Consolidated Statements of Shareholders' Equity - USD ($) $ in Thousands	Total	Common Shares	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Common Shares in Treasury, at cost
Beginning balance at Oct. 31, 2021	$ 2,159,130	$ 12,253	$ 585,334	$ 3,265,027	$ (175,835)	$ (1,527,649)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares issued under company stock and employee benefit plans	5,721		5,046			675
Stock-based compensation	8,392		8,392
Purchase of treasury shares	(35,002)					(35,002)
Dividends declared	(29,724)			(29,724)
Net income	120,409			120,409
Components of other comprehensive income (loss):
Foreign currency translation adjustments	(13,358)				(13,358)
Defined benefit pension and post-retirement plan adjustments	3,060				3,060
Ending balance at Jan. 31, 2022	2,218,628	12,253	598,772	3,355,712	(186,133)	(1,561,976)
Beginning balance at Oct. 31, 2021	2,159,130	12,253	585,334	3,265,027	(175,835)	(1,527,649)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	371,854
Components of other comprehensive income (loss):
Foreign currency translation adjustments	(81,479)
Pension settlement, net of tax of ($0)	32,047
Ending balance at Jul. 31, 2022	2,199,045	12,253	616,567	3,548,206	(217,581)	(1,760,400)
Beginning balance at Jan. 31, 2022	2,218,628	12,253	598,772	3,355,712	(186,133)	(1,561,976)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares issued under company stock and employee benefit plans	2,077		1,843			234
Stock-based compensation	7,394		7,394
Purchase of treasury shares	(105,464)					(105,464)
Dividends declared	(29,577)			(29,577)
Net income	109,634			109,634
Components of other comprehensive income (loss):
Foreign currency translation adjustments	(46,901)				(46,901)
Pension settlement, net of tax of ($0)	32,047				32,047
Defined benefit pension and post-retirement plan adjustments	2,778				2,778
Ending balance at Apr. 30, 2022	2,190,616	12,253	608,009	3,435,769	(198,209)	(1,667,206)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares issued under company stock and employee benefit plans	1,047		940			107
Stock-based compensation	7,618		7,618
Purchase of treasury shares	(93,301)					(93,301)
Dividends declared	(29,374)			(29,374)
Net income	141,811			141,811
Components of other comprehensive income (loss):
Foreign currency translation adjustments	(21,220)				(21,220)
Pension settlement, net of tax of ($0)	0
Defined benefit pension and post-retirement plan adjustments	1,848				1,848
Ending balance at Jul. 31, 2022	2,199,045	12,253	616,567	3,548,206	(217,581)	(1,760,400)
Beginning balance at Oct. 31, 2022	2,294,375	12,253	626,697	3,652,216	(207,782)	(1,789,009)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares issued under company stock and employee benefit plans	8,807		7,032			1,775
Stock-based compensation	7,071		7,071
Purchase of treasury shares	(6,875)					(6,875)
Dividends declared	(37,199)			(37,199)
Net income	104,261			104,261
Components of other comprehensive income (loss):
Foreign currency translation adjustments	76,821				76,821
Defined benefit pension and post-retirement plan adjustments	(576)				(576)
Ending balance at Jan. 31, 2023	2,446,685	12,253	640,800	3,719,278	(131,537)	(1,794,109)
Beginning balance at Oct. 31, 2022	2,294,375	12,253	626,697	3,652,216	(207,782)	(1,789,009)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	359,715
Components of other comprehensive income (loss):
Foreign currency translation adjustments	79,986
Pension settlement, net of tax of ($0)	0
Ending balance at Jul. 31, 2023	2,579,806	12,253	660,218	3,900,384	(128,704)	(1,864,345)
Beginning balance at Jan. 31, 2023	2,446,685	12,253	640,800	3,719,278	(131,537)	(1,794,109)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares issued under company stock and employee benefit plans	3,001		2,632			369
Stock-based compensation	4,970		4,970
Purchase of treasury shares	(47,490)					(47,490)
Dividends declared	(37,264)			(37,264)
Net income	127,563			127,563
Components of other comprehensive income (loss):
Foreign currency translation adjustments	(290)				(290)
Defined benefit pension and post-retirement plan adjustments	(173)				(173)
Ending balance at Apr. 30, 2023	2,497,002	12,253	648,402	3,809,577	(132,000)	(1,841,230)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares issued under company stock and employee benefit plans	6,641		5,958			683
Stock-based compensation	5,858		5,858
Purchase of treasury shares	(23,798)					(23,798)
Dividends declared	(37,084)			(37,084)
Net income	127,891			127,891
Components of other comprehensive income (loss):
Foreign currency translation adjustments	3,455				3,455
Pension settlement, net of tax of ($0)	0
Defined benefit pension and post-retirement plan adjustments	(159)				(159)
Ending balance at Jul. 31, 2023	$ 2,579,806	$ 12,253	$ 660,218	$ 3,900,384	$ (128,704)	$ (1,864,345)

Consolidated Statements of Sh_2

Consolidated Statements of Shareholders' Equity (Parenthetical) - $ / shares	3 Months Ended
	Jul. 31, 2023	Apr. 30, 2023	Jan. 31, 2023	Jul. 31, 2022	Apr. 30, 2022	Jan. 31, 2022
Statement of Stockholders' Equity [Abstract]
Dividends declared (in dollars per share)	$ 0.65	$ 0.65	$ 0.65	$ 0.51	$ 0.51	$ 0.51

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Jul. 31, 2023	Jul. 31, 2022
Cash flows from operating activities:
Net income	$ 359,715	$ 371,854
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	80,637	75,242
Non-cash stock compensation	17,067	23,404
Deferred income taxes	(930)	(11,094)
Other non-cash expense	762	43,325
Loss on sale of property, plant and equipment	1,624	(707)
Changes in operating assets and liabilities	19,197	(162,333)
Net cash provided by operating activities	478,072	339,691
Cash flows from investing activities:
Additions to property, plant and equipment	(24,244)	(39,373)
Proceeds from sale of property, plant and equipment	91	415
Acquisition of business, net of cash acquired	(377,843)	(171,613)
Net cash used in investing activities	(401,996)	(210,571)
Cash flows from financing activities:
Proceeds from long-term debt	1,279,151	63,067
Repayment of long-term debt	(1,205,195)	(40,162)
Repayment of finance lease obligations	(4,769)	(3,726)
Issuance of common shares	18,449	8,845
Purchase of treasury shares	(78,163)	(233,767)
Dividends paid	(111,547)	(88,675)
Net cash used in financing activities	(102,074)	(294,418)
Effect of exchange rate changes on cash	5,679	(5,937)
Decrease in cash and cash equivalents	(20,319)	(171,235)
Cash and cash equivalents at beginning of period	163,457	299,972
Cash and cash equivalents at end of period	$ 143,138	$ 128,737

Significant accounting policies

Significant accounting policies	9 Months Ended
	Jul. 31, 2023
Accounting Policies [Abstract]
Significant accounting policies	Significant accounting policies Basis of presentation . The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by generally accepted accounting principles in the United States (U.S. GAAP) for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the nine months ended July 31, 2023 are not necessarily indicative of the results that may be expected for the full year. For further information, refer to the Consolidated Financial Statements and notes included in our Annual Report on Form 10-K for the year ended October 31, 2022. Consolidation . The Condensed Consolidated Financial Statements include the accounts of Nordson Corporation and its 100%-owned and controlled subsidiaries. Investments in affiliates and joint ventures in which our ownership is 50% or less or in which we do not have control but have the ability to exercise significant influence, are accounted for under the equity method. All significant intercompany accounts and transactions have been eliminated in consolidation. Use of estimates . The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect the amounts reported in the Condensed Consolidated Financial Statements. Actual amounts could differ from these estimates. Revenue recognition . A contract exists when it has approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of the consideration is probable. Revenue is recognized when performance obligations under the terms of the contract with a customer are satisfied. Generally, our revenue results from short-term, fixed-price contracts and primarily is recognized as of a point in time when the product is shipped or at a later point when the control of the product transfers to the customer. Revenue for undelivered items is deferred and included within Accrued liabilities in our Consolidated Balance Sheets. Revenues deferred as of July 31, 2023 and 2022 were not material. However, for certain contracts related to the sale of customer-specific products within our Medical and Fluid Solutions segment, revenue is recognized over time as we satisfy performance obligations because of the continuous transfer of control to the customer. The continuous transfer of control to the customer occurs as we enhance assets that are customer controlled and we are contractually entitled to payment for work performed to date plus a reasonable margin. As control transfers over time, revenue is recognized based on progress toward completion of the performance obligations. The selection method to measure progress towards completion requires judgment and is based on the nature of the products or services to be provided. We have elected to use the input method – costs incurred for these contracts because it best depicts the transfer of products or services to the customer based on incurring costs on the contract. Under this method, revenues are recorded proportionally as costs are incurred. Contract assets recognized are recorded in Prepaid expenses and other current assets and contract liabilities are recorded in Accrued liabilities in our Consolidated Balance Sheets and were not material on July 31, 2023 and October 31, 2022. Revenue recognized over time represented approximately less than ten percent of our overall consolidated revenues at July 31, 2023 and October 31, 2022. Revenue is measured as the amount of consideration we expect to receive in exchange for transferring products or services. Taxes, including sales and value add, that we collect concurrently with revenue-producing activities are excluded from revenue. As a practical expedient, we may exclude the assessment of whether goods or services are performance obligations, if they are immaterial in the context of the contract, and combine these with other performance obligations. While payment terms and conditions vary by contract type, we have determined that our contracts generally do not include a significant financing component. We have elected to apply the practical expedient to treat all shipping and handling costs as fulfillment costs as a significant portion of these costs are incurred prior to transfer of control to the customer. We have also elected to apply the practical expedient to expense sales commissions as they are incurred as the amortization period resulting from capitalizing the costs is one year or less. These costs are recorded within Selling and administrative expenses in our Condensed Consolidated Statements of Income. We offer assurance-type warranties on our products as well as separately sold warranty contracts. Revenue related to warranty contracts that are sold separately is recognized over the life of the warranty term and are not material. Certain arrangements may include installation, installation supervision, training, and spare parts, which tend to be completed in a short period of time, at an insignificant cost, and utilizing skills not unique to us, and, therefore, these items are typically regarded as inconsequential or not material. We disclose disaggregated revenues by operating segment and geography in accordance with the revenue standard and on the same basis used internally by the chief operating decision maker for evaluating performance of operating segments and for allocating resources. Refer to our Operating segments Note for details. Earnings per share . Basic earnings per share are computed based on the weighted-average number of common shares outstanding during each year, while diluted earnings per share are based on the weighted-average number of common shares and common share equivalents outstanding. Common share equivalents consist of shares issuable upon exercise of stock options computed using the treasury stock method, as well as restricted shares and deferred stock-based compensation. Options whose exercise price is higher than the average market price are excluded from the calculation of diluted earnings per share because the effect would be anti-dilutive. Options excluded from the calculation of diluted earnings per share for the three months ended July 31, 2023 and 2022 were 138 and 76, respectively. Options excluded from the calculation of diluted earnings per share for the nine months ended July 31, 2023 and 2022 were 141 and 79, respectively.

Recently issued accounting stan

Recently issued accounting standards	9 Months Ended
	Jul. 31, 2023
Accounting Changes and Error Corrections [Abstract]
Recently issued accounting standards	Recently issued accounting standardsThere have been no new accounting standards issued which would require either disclosure or adoption during the current periods.

Acquisitions

Acquisitions	9 Months Ended
	Jul. 31, 2023
Business Combination and Asset Acquisition [Abstract]
Acquisitions	Acquisitions Business acquisitions have been accounted for using the acquisition method, with the acquired assets and liabilities recorded at estimated fair value on the dates of acquisition. The cost in excess of the net assets of the business acquired is included in goodwill. Operating results since the respective dates of acquisitions are included in the Condensed Consolidated Statements of Income. 2023 Acquisitions On August 24, 2023, the Company completed the acquisition of the ARAG Group and its subsidiaries (ARAG Group or ARAG) pursuant to the terms of the Sale and Purchase Agreement, dated as of June 25, 2023, by and among the Company, its Italian subsidiary, Capvis Equity V LP (Capvis), DRIP Co-Investment (DRIP), and certain individuals (the Individual Sellers, and together with Capvis and DRIP, collectively, the Sellers). ARAG is a global market and innovation leader in the development, production and supply of precision control systems and smart fluid components for agricultural spraying. ARAG will operate as a division of our Industrial Precision Solutions segment. In anticipation of the acquisition, the Company entered into a €760,000 senior unsecured term loan facility with a group of banks in August 2023 (the Term F acility ). The Term Facility has a 364-day term and matures in August 2024, and loans under the facility bear interest at a eurocurrency rate plus an applicable margin that will range from 1.1250% to 1.625% based on the Company’s Leverage Ratio (as defined in the term loan credit agreement and calculated on a consolidated net debt basis). The all-cash ARAG acquisition of approximately €957,000, net of the repayment of approximately €30,300 of debt of the acquired companies, was funded using the Term Facility and Revolving Facility. The financial results of the ARAG Group acquisition are not expected to have a material impact on our Consolidated Financial Statements. On November 3, 2022, we acquired 100% of CyberOptics Corporation (CyberOptics). CyberOptics is a leading global developer and manufacturer of high-precision 3D optical sensing technology solutions. The CyberOptics acquisition expanded our test and inspection platform, providing differentiated technology that expands our product offering in the semiconductor and electronics industries and is reported in our Advanced Technology Solutions segment. We acquired CyberOptics for an aggregate purchase price of $377,843, net of cash of approximately $40,890, funded using borrowings under our revolving credit facility and cash on hand. Based on the fair value of the assets acquired and the liabilities assumed, goodwill of $279,630 and identifiable intangible assets of $58,600 were recorded. The identifiable intangible assets consist primarily of $15,200 of tradenames (amortized over fifteen years), $14,600 of technology (amortized over seven years), and $28,800 of customer contracts (amortized over twelve years). T he results of CyberOptics are not material to our Consolidated Financial Statements. As of July 31, 2023, t he purchase price allocation remains preliminary as we complete our assessment of intangibles and income taxes. The assets and liabilities acquired were as follows: November 3, 2022 Cash $ 40,890 Receivables - net 21,364 Inventories - net 35,300 Goodwill 279,630 Intangibles 58,600 Other assets 14,046 Total Assets $ 449,830 Accounts payable $ 8,109 Deferred income taxes 14,294 Other liabilities 8,694 Total Liabilities $ 31,097 2022 Acquisition

Receivables

Receivables	9 Months Ended
	Jul. 31, 2023
Credit Loss [Abstract]
Receivables	Receivables Our allowance for credit losses is principally determined based on aging of receivables. Receivables are exposed to credit risk based on the customers' ability to pay which is influenced by, among other factors, their financial liquidity. We perform ongoing customer credit evaluation to maintain sufficient allowances for potential credit losses. Our segments perform credit evaluation and monitoring to estimate and manage credit risk through the review of customer information, credit ratings, approval and monitoring of customer credit limits, and assessment of market conditions. We may also require prepayments or bank guarantees from customers to mitigate credit risk. Our receivables are generally short-term in nature with a majority of receivables outstanding less than 90 days. Accounts receivable balances are written-off against the allowance if deemed uncollectible. Accounts receivable are net of an allowance for credit losses of $8,076 and $8,218 on July 31, 2023 and October 31, 2022, respectively. Provision losses related to allowance for credit losses of $410 and provision income of $239 was recorded for the three and nine months ended July 31, 2023, respectively, compared to provision expense of $788 and $1,439 for the same periods a year ago, respectively. The remaining change in the allowance for credit losses is principally related to net write-off/recoveries of uncollectible accounts as well as currency translation.

Inventories

Inventories	9 Months Ended
	Jul. 31, 2023
Inventory Disclosure [Abstract]
Inventories	Inventories Components of inventories were as follows: July 31, 2023 October 31, 2022 Finished goods $ 234,690 $ 218,491 Raw materials and component parts 200,475 157,447 Work-in-process 62,856 53,195 498,021 429,133 Obsolescence and other reserves (58,280) (45,735) $ 439,741 $ 383,398 See Acquisitions Note for inventory increase attributable to acquisition of CyberOptics.

Property, Plant and Equipment

Property, Plant and Equipment	9 Months Ended
	Jul. 31, 2023
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment	Property, Plant and Equipment Components of property, plant and equipment were as follows: July 31, 2023 October 31, 2022 Land $ 9,856 $ 9,278 Land improvements 5,033 4,979 Buildings 282,260 271,450 Machinery and equipment 536,215 505,343 Enterprise management system 52,938 52,513 Construction-in-progress 20,130 31,466 Leased property under finance leases 28,047 27,512 934,479 902,541 Accumulated depreciation and amortization (583,744) (549,099) $ 350,735 $ 353,442

Goodwill and other intangible a

Goodwill and other intangible assets	9 Months Ended
	Jul. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and other intangible assets	Goodwill and other intangible assets Changes in the carrying amount of goodwill for th e nine months ended July 31, 2023 by operating segment were as follows: Industrial Medical Fluid Systems Advanced Total Balance at October 31, 2022 $ 520,236 $ 1,172,069 $ 112,388 $ 1,804,693 Acquisitions — — 279,630 279,630 Currency effect 4,744 3,869 17,844 26,457 Balance at July 31, 2023 $ 524,980 $ 1,175,938 $ 409,862 $ 2,110,780 The increase in goodwill for the nine months ended July 31, 2023 was due to the acquisition of CyberOptics. See Acquisitions Note for additional details. Information regarding our intangible assets subject to amortization was as follows: July 31, 2023 Carrying Accumulated Net Book Customer relationships $ 517,147 $ 282,598 $ 234,549 Patent/technology costs 176,396 109,783 66,613 Trade name 99,413 50,673 48,740 Non-compete agreements 10,559 9,937 622 Other 143 143 — Total $ 803,658 $ 453,134 $ 350,524 October 31, 2022 Carrying Accumulated Net Book Customer relationships $ 480,058 $ 250,798 $ 229,260 Patent/technology costs 157,549 96,426 61,123 Trade name 82,759 44,707 38,052 Non-compete agreements 10,253 9,290 963 Other 446 442 4 Total $ 731,065 $ 401,663 $ 329,402 Amortization expense for the three months ended July 31, 2023 and 2022 was $13,922 and $12,709, respectively. Amortization expense for the nine months ended July 31, 2023 and 2022 was $41,839 and $38,366, respectively. See Acquisitions Note for details regarding intangibles recorded due to the acquisition of CyberOptics.

Pension and other postretiremen

Pension and other postretirement plans	9 Months Ended
	Jul. 31, 2023
Retirement Benefits [Abstract]
Pension and other postretirement plans	Pension and other postretirement plans During the second quarter of 2022, we completed a partial plan settlement transaction in regards to two of our U.S. pension plans in which plan assets amounting to $171,181 were used to purchase a group annuity contract from The Prudential Insurance Company of America (Prudential). The settlement resulted in a loss of $41,221, which is included in Other-net on the Condensed Consolidated Statements of Income. This transaction relieved the Company of its responsibility for the pension obligation related to certain retired employees and transferred the obligation and payment responsibility to Prudential for retirement benefits owed to approximately 1,500 retirees and other beneficiaries. The annuity contract covered retirees who commenced receiving benefits on or before November 1, 2021. The monthly retirement benefit payment amounts currently received by retirees and their beneficiaries did not change as a result of this transaction. Plan participants not included in the transaction remain in the plans and responsibility for payment of the retirement benefits remains with the Company. The components of net periodic pension and other postretirement cost for the three and nine months ended July 31, 2023 and 2022 were: U.S. International Three Months Ended 2023 2022 2023 2022 Service cost $ 2,744 $ 3,423 $ 281 $ 423 Interest cost 4,176 3,322 642 272 Expected return on plan assets (6,529) (5,692) (392) (347) Amortization of prior service cost (credit) — 12 (13) (13) Amortization of net actuarial loss — 1,197 20 558 Total benefit cost $ 391 $ 2,262 $ 538 $ 893 U.S. International Nine Months Ended 2023 2022 2023 2022 Service cost $ 8,233 $ 13,338 $ 838 $ 1,343 Interest cost 12,526 11,146 1,887 861 Expected return on plan assets (19,587) (22,082) (1,151) (1,109) Amortization of prior service cost (credit) — 36 (38) (43) Amortization of net actuarial loss — 6,282 61 1,758 Settlement loss — 41,221 — — Total benefit cost $ 1,172 $ 49,941 $ 1,597 $ 2,810 The components of other postretirement benefit costs for the three and nine months ended July 31, 2023 and 2022 were: U.S. International Three Months Ended 2023 2022 2023 2022 Service cost $ 100 $ 172 $ 1 $ 3 Interest cost 766 481 3 3 Amortization of net actuarial (gain) loss — 244 (16) (12) Total benefit cost (income) $ 866 $ 897 $ (12) $ (6) U.S. International Nine Months Ended 2023 2022 2023 2022 Service cost $ 299 $ 515 $ 4 $ 9 Interest cost 2,297 1,443 8 10 Amortization of net actuarial (gain) loss — 733 (47) (37) Total benefit cost (income) $ 2,596 $ 2,691 $ (35) $ (18) The components of net periodic pension and other postretirement cost other than service cost are included in Other – net in our Condensed Consolidated Statements of Income.

Income taxes

Income taxes	9 Months Ended
	Jul. 31, 2023
Income Tax Disclosure [Abstract]
Income taxes	Income taxes We record our interim provision for income taxes based on our estimated annual effective tax rate, as well as certain items discrete to the current periods. The effective tax rate for the three months ended July 31, 2023 and 2022 was 21.1% and 21.4%, respectively. The effective tax rate for the nine months ended July 31, 2023 and 2022 was 20.9% and 21.2%, respectively.

Accumulated other comprehensive

Accumulated other comprehensive loss	9 Months Ended
	Jul. 31, 2023
Equity [Abstract]
Accumulated other comprehensive loss	Accumulated other comprehensive income (loss) The components of accumulated other comprehensive income (loss), including adjustments for items that are reclassified from accumulated other comprehensive loss to net income, are shown below. Cumulative Pension and Accumulated Balance at October 31, 2022 $ (160,046) $ (47,736) $ (207,782) Pension and other postretirement plan adjustments, net of tax of ($305) — (908) (908) Foreign currency translation adjustments (a) 79,986 — 79,986 Balance at July 31, 2023 $ (80,060) $ (48,644) $ (128,704) (a) Includes a net loss of $3,672, net of tax of $1,097, on net investment hedges.

Stock-based compensation

Stock-based compensation	9 Months Ended
	Jul. 31, 2023
Share-Based Payment Arrangement [Abstract]
Stock-based compensation	Stock-based compensation During the 2021 Annual Meeting of Shareholders, our shareholders approved the Nordson Corporation 2021 Stock Incentive and Award Plan (the 2021 Plan) as the successor to the Amended and Restated 2012 Stock Incentive and Award Plan (the 2012 Plan). The 2021 Plan provides for the granting of stock options, stock appreciation rights, restricted shares, restricted share units, performance shares, cash awards and other stock or performance-based incentives. A maximum of 900 common shares were authorized for grant under the 2021 Plan plus the number of shares that remained available to be granted under the 2012 Plan, as well as issuable under the CyberOptics equity plan. As of July 31, 2023, a total of 2,012 common shares were available to be granted under the 2021 Plan. Stock Options Nonqualified or incentive stock options may be granted to our employees and directors. Generally, options granted to employees may be exercised beginning one year from the date of grant at a rate not exceeding 25% per year and expire 10 years from the date of grant. Vesting accelerates upon a qualified termination in connection with a change in control. In the event of termination of employment due to early retirement or normal retirement at age 65, options granted within 12 months prior to termination are forfeited, and vesting continues post retirement for all other unvested options granted. In the event of disability or death, all unvested stock options granted within 12 months prior to termination fully vest. Termination for any other reason results in forfeiture of unvested options and vested options in certain circumstances. The amortized cost of options is accelerated if the retirement eligibility date occurs before the normal vesting date. Option exercises are satisfied through the issuance of treasury shares on a first-in, first-out basis. We recognized compensation expense related to stock options of $1,697 and $4,982 for the three month and nine months ended July 31, 2023, respectively, compared to $1,580 and $5,743 for the three and nine months ended July 31, 2022, respectively. The following table summarizes activity related to stock options for the nine months ended July 31, 2023: Number of Weighted- Aggregate Weighted Outstanding at October 31, 2022 1,187 $ 141.82 Granted 80 239.44 Exercised (163) 115.67 Forfeited or expired (10) 206.93 Outstanding at July 31, 2023 1,094 $ 151.09 $ 111,165 5.1 years Expected to vest 245 $ 214.42 $ 10,006 7.5 years Exercisable at July 31, 2023 846 $ 132.58 $ 101,014 4.4 years As of July 31, 2023, there was $7,013 of total unrecognized compensation cost related to unvested stock options. That cost is expected to be amortized over a weighted average period of approximately 1.7 years. The fair value of each option grant was estimated at the date of grant using the Black-Scholes option-pricing model with the following assumptions: Nine Months Ended July 31, 2023 July 31, 2022 Expected volatility 30.4% - 31.8% 30.6% - 30.8% Expected dividend yield 1.12% - 1.27% 0.76% - 0.76% Risk-free interest rate 3.79% - 4.21% 1.36% - 1.47% Expected life of the option (in years) 5.0 - 6.2 5.3 - 6.2 The weighted-average expected volatility used to value the 2023 and 2022 options was 30.6% and 30.6%, respectively. Historical information was the primary basis for the selection of the expected volatility, expected dividend yield and the expected lives of the options. The risk-free interest rate was selected based upon yields of U.S. Treasury issues with a term equal to the expected life of the option being valued. The weighted average grant date fair value of stock options granted during the nine months ended July 31, 2023 and 2022 was $77.99 and $79.03, respectively. The total intrinsic value of options exercised during the three months ended July 31, 2023 and 2022 was $7,741 and $1,052, respectively. The total intrinsic value of options exercised during the nine months ended July 31, 2023 and 2022 was $19,873 and $10,418, respectively. Cash received from the exercise of stock options for the nine months ended July 31, 2023 and 2022 was $18,449 and $8,845, respectively. Restricted Shares and Restricted Share Units We may grant restricted shares and/or restricted share units to our employees and directors. These shares or units may not be transferred for a designated period of time (generally one For employee recipients, in the event of termination of employment due to early retirement, with the consent of the Company, restricted shares and units granted within 12 months prior to termination are forfeited, and other restricted shares and units vest on a pro-rata basis, subject to the consent of the Compensation Committee. In the event of termination of employment due to normal retirement at age 65, restricted shares and units granted within 12 months prior to termination are forfeited, and, for other restricted shares and units, the restriction period applicable to restricted shares will lapse and the shares will vest and be transferable and all unvested units will become vested in full, subject to the consent of the Compensation Committee. In the event of a recipient's disability or death, all restricted shares and units granted within 12 months prior to termination fully vest. Termination for any other reason prior to the lapse of any restrictions or vesting of units results in forfeiture of the shares or units. For non-employee directors, all restrictions lapse in the event of disability or death of the non-employee director. Termination of service as a director for any other reason within one year of date of grant results in a pro-rata vesting of shares or units. As shares or units are issued, deferred stock-based compensation equivalent to the fair value on the date of grant is expensed over the vesting period. The following table summarizes activity related to restricted shares during the nine months ended July 31, 2023: Number of Shares Weighted-Average Restricted shares at October 31, 2022 6 $ 167.99 Vested (6) 167.99 Restricted shares at July 31, 2023 — $ — As of July 31, 2023, there was no unrecognized compensation cost related to restricted shares. The amount charged to expense related to restricted shares during the three months ended July 31, 2023 and 2022 was $73 and $243, respectively, which included common share dividends of $2 and $4, respectively. For the nine months ended July 31, 2023 and 2022, the amounts charged to expense related to restricted shares were $336 and $856, respectively, which included common shares dividends of $5 and $14, respectively. The following table summarizes activity related to restricted share units during the nine months ended July 31, 2023: Number of Units Weighted-Average Restricted share units at October 31, 2022 81 $ 223.77 Granted 39 237.18 Forfeited (5) 241.37 Vested (45) 219.06 Restricted share units at July 31, 2023 70 $ 232.88 As of July 31, 2023, there was $10,080 of remaining expense to be recognized related to outstanding restricted share units, which is expected to be recognized over a weighted average period of 1.8 years. The amount charged to expense related to restricted share units during each of the three months ended July 31, 2023 and 2022 was $2,152 and $2,154, respectively, compared to $6,658 and $6,246 for the nine months ended July 31, 2023 and 2022, respectively. Performance Share Incentive Awards Executive officers and selected other key employees are eligible to receive common share-based incentive awards. Payouts, in the form of unrestricted common shares, vary based on the degree to which corporate financial performance exceeds predetermined threshold, target and maximum performance goals over three-year performance periods. No payout will occur unless threshold performance is achieved. The amount of compensation expense is based upon current performance projections and the percentage of the requisite service that has been rendered. The calculations are based upon the grant date fair value, which is principally driven by the stock price on the date of grant or a Monte Carlo valuation for awards with market conditions. The per share values were $231.34, $211.25 and $214.51 in 2023, and $260.60, $273.50 and $221.94 for 2022. The amount charged to expense related to performance awards for the three months ended July 31, 2023 and 2022 was $1,831 and $3,555, respectively, compared to charges of $4,785 and $10,296 for the nine months ended July 31, 2023 and 2022, respectively. As of July 31, 2023, there was $7,947 of unrecognized compensation cost related to performance share incentive awards. Deferred Compensation Our executive officers and other highly compensated employees may elect to defer up to 100% of their base pay and cash incentive compensation, and for executive officers, up to 90% of their share-based performance incentive payout each year. Additional share units are credited for quarterly dividends paid on our common shares. Expense related to dividends paid under this plan for the three months ended July 31, 2023 and 2022 was $30 and $17, respectively, compared to $77 and $53 for the nine months ended July 31, 2023 and 2022, respectively. Deferred Directors' Compensation Non-employee directors may defer all or part of their cash and equity-based compensation until retirement. Cash compensation may be deferred as cash or as share equivalent units. Deferred cash amounts are recorded as liabilities, and share equivalent units are recorded as equity. Additional share equivalent units are earned when common share dividends are declared. The following table summarizes activity related to director deferred compensation share equivalent units during the nine months ended July 31, 2023: Number of Shares Weighted-Average Outstanding at October 31, 2022 90 $ 77.70 Distributions (13) 52.50 Outstanding at July 31, 2023 78 $ 84.02

Warranties

Warranties	9 Months Ended
	Jul. 31, 2023
Guarantees [Abstract]
Warranties	Warranties We offer warranties to our customers depending on the specific product and terms of the customer purchase agreement. A typical warranty program requires that we repair or replace defective products within a specified time period (generally one year) from the date of delivery or first use. We record an estimate for future warranty-related costs based on actual historical return rates. Based on analysis of return rates and other factors, the adequacy of our warranty provisions is adjusted as necessary. The liability for warranty costs is included in Accrued liabilities in the Consolidated Balance Sheets. Following is a reconciliation of the product warranty liability for the nine months ended July 31, 2023 and 2022: July 31, 2023 July 31, 2022 Beginning balance at October 31 $ 11,723 $ 11,113 Accruals for warranties 14,938 12,496 Warranty payments (12,939) (10,704) Currency effect 566 (676) Ending balance $ 14,288 $ 12,229

Operating segments

Operating segments	9 Months Ended
	Jul. 31, 2023
Segment Reporting [Abstract]
Operating segments	Operating segments We conduct business in three p rimary operating segments: Industrial Precision Solutions, Medical and Fluid Solutions, and Advanced Technology Solutions. The composition of segments and measure of segment profitability is consistent with that used by our chief operating decision maker. The primary measure used by the chief operating decision maker for purposes of making decisions about allocating resources to the segments and assessing performance is operating profit, which equals sales less cost of sales and certain operating expenses. Items below the operating profit line of the Condensed Consolidated Statements of Income (interest and investment income, interest expense and other income/expense) are excluded from the measure of segment profitability reviewed by our chief operating decision maker and are not presented by operating segment. The accounting policies of the segments are the same as those described in the Significant accounting policies Note. Industrial Precision Solutions: This segment focuses on delivering proprietary dispensing and processing technology, both standard and highly customized equipment, to diverse end markets. Product lines commonly reduce material consumption, increase line efficiency through precision dispense and measurement and control, and enhance product brand and appearance. Components are used for dispensing adhesives, coatings, paint, finishes, sealants and other materials. This segment primarily serves the industrial, consumer durables and non-durables markets. Medical and Fluid Solutions: This segment includes the Company’s fluid management solutions for medical, high-tech industrial and other diverse end markets. Related plastic tubing, balloons, catheters, syringes, cartridges, tips and fluid connection components are used to dispense or control fluids within customers’ medical devices or products, as well as production processes. Advanced Technology Solutions: This segment focuses on products serving electronics end markets. Advanced Technology Solutions products integrate our proprietary product technologies found in progressive stages of an electronics customer’s production processes, such as surface treatment, precisely controlled dispensing of material and test and inspection to ensure quality and reliability. Applications include, but are not limited to, semiconductors, printed circuit boards, electronic components and automotive electronics. The following table presents information about our segments: Three Months Ended Industrial Medical and Fluid Solutions Advanced Corporate Total July 31, 2023 Net external sales $ 338,257 $ 170,871 $ 139,549 $ — $ 648,677 Operating profit (loss) 115,346 54,019 27,083 (25,452) 170,996 July 31, 2022 Net external sales $ 341,215 $ 177,840 $ 143,073 $ — $ 662,128 Operating profit (loss) 119,706 58,103 28,155 (21,046) 184,918 Nine Months Ended July 31, 2023 Net external sales $ 985,610 $ 491,683 $ 432,026 $ — $ 1,909,319 Operating profit (loss) 329,439 141,326 70,136 (53,179) 487,722 July 31, 2022 Net external sales $ 981,582 $ 508,836 $ 416,279 $ — $ 1,906,697 Operating profit (loss) 324,089 165,510 95,533 (60,381) 524,751 We had significant sales in the following geographic regions: Three Months Ended Nine Months Ended July 31, 2023 July 31, 2022 July 31, 2023 July 31, 2022 Americas $ 290,515 $ 279,205 $ 834,125 $ 792,859 Europe 167,536 151,659 498,379 479,900 Asia Pacific 190,626 231,264 576,815 633,938 Total net external sales $ 648,677 $ 662,128 $ 1,909,319 $ 1,906,697

Fair value measurements

Fair value measurements	9 Months Ended
	Jul. 31, 2023
Fair Value Disclosures [Abstract]
Fair value measurements	Fair value measurements The inputs to the valuation techniques used to measure fair value are classified into the following categories: Level 1: Quoted market prices in active markets for identical assets or liabilities. Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data. Level 3: Unobservable inputs that are not corroborated by market data. The following tables present the classification of our assets and liabilities measured at fair value on a recurring basis: July 31, 2023 Total Level 1 Level 2 Level 3 Assets: Foreign currency forward contracts (a) $ 9,608 $ — $ 9,608 $ — Net investment contracts (b) 3,036 — 3,036 — Total assets at fair value $ 12,644 $ — $ 12,644 $ — Liabilities: Deferred compensation plans (c) $ 10,636 $ — $ 10,636 $ — Foreign currency forward contracts (a) 4,209 — 4,209 — Net investment contracts (b) 4,601 — 4,601 — Total liabilities at fair value $ 19,446 $ — $ 19,446 $ — October 31, 2022 Total Level 1 Level 2 Level 3 Assets: Foreign currency forward contracts (a) $ 5,035 $ — $ 5,035 $ — Total assets at fair value $ 5,035 $ — $ 5,035 $ — Liabilities: Deferred compensation plans (b) $ 9,076 $ — $ 9,076 $ — Foreign currency forward contracts (a) 11,724 — 11,724 — Total liabilities at fair value $ 20,800 $ — $ 20,800 $ — (a) We enter into foreign currency forward contracts to reduce the risk of foreign currency exposures resulting from receivables, payables, intercompany receivables, intercompany payables and loans denominated in foreign currencies. Foreign exchange contracts are valued using market exchange rates. These foreign exchange contracts are not designated as hedges. (b) Net assets of our foreign subsidiaries are exposed to volatility in foreign currency exchange rates. We utilize net investment hedges to offset the translation adjustment arising from re-measuring our investment in foreign subsidiaries. The notional amount of our net investment hedge contracts as of July 31, 2023 was $385,000. (c) Executive officers and other highly compensated employees may defer up to 100% of their salary and annual cash incentive compensation and for executive officers, up to 90% of their long-term incentive compensation, into various non-qualified deferred compensation plans. Deferrals can be allocated to various market performance measurement funds. Changes in the value of compensation deferred under these plans are recognized each period based on the fair value of the underlying measurement funds. The carrying amounts and fair values of financial instruments, other than cash and cash equivalents, receivables, and accounts payable, are shown in the table below. The carrying values of cash and cash equivalents, receivables and accounts payable approximate fair value due to the short-term nature of these instruments. July 31, 2023 Carrying Amount Fair Value Long-term debt (including current portion) $ 838,098 $ 836,098 Long-term debt is valued by discounting future cash flows at currently available rates for borrowing arrangements with similar terms and conditions, which are considered to be Level 2 inputs under the fair value hierarchy. The carrying amount of long-term debt is shown net of unamortized debt issuance costs as disclosed in the Long-term Debt Note.

Derivative financial instrument

Derivative financial instruments	9 Months Ended
	Jul. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative financial instruments	Derivative financial instruments Foreign Currency Forward Contracts We operate internationally and enter into intercompany transactions denominated in foreign currencies. Consequently, we are subject to market risk arising from exchange rate movements between the dates foreign currency transactions occur and the dates they are settled. We regularly use foreign currency forward contracts to reduce our risks related to most of these transactions. These contracts usually have maturities of 90 days or less and generally require us to exchange foreign currencies for U.S. dollars at maturity, at rates stated in the contracts. These contracts are not designated as hedging instruments under U.S. GAAP. Accordingly, the changes in the fair value of the foreign currency forward contracts are recognized in each accounting period in “Other – net” on the Condensed Consolidated Statements of Income together with the transaction gain or loss from the related balance sheet position. For the three months ended July 31, 2023, we recognized a net loss of $93 on foreign currency forward contracts and a net loss of $885 from the change in fair value of balance sheet positions. For the three months ended July 31, 2022, we recognized a net gain of $15,181 on foreign currency forward contracts and a net loss of $14,436 from the change in fair value of balance sheet positions. For the nine months ended July 31, 2023, we recognized a net gain of $12,086 on foreign currency forward contracts and a net loss of $19,710 from the change in fair value of balance sheet positions. For the nine months ended July 31, 2022, we recognized a net gain of $2,503 on foreign currency forward contracts and a net loss of $394 from the change in fair value of balance sheet positions. The fair values of our foreign currency forward contract assets and liabilities are included in Receivable-net and Accrued liabilities, respectively, in our Consolidated Balance Sheets. The following table summarizes, by currency, the foreign currency forward contracts outstanding at July 31, 2023 and 2022: July 31, 2023 contract amounts: Notional Sell Amounts Notional Buy Amounts Euro $ 95,064 $ 194,850 British pound 20,489 132,956 Japanese yen 23,195 17,908 Mexican Peso 3,227 28,158 Hong Kong dollar 2,080 7,265 Singapore dollar 60 19,817 Australian dollar — 9,236 Taiwan Dollar — 8,000 Others 2,602 71,830 Total $ 146,717 $ 490,020 July 31, 2022 contract amounts: Notional Sell Amounts Notional Buy Amounts Euro $ 88,275 $ 333,285 British pound 36,779 78,942 Japanese yen 16,688 37,163 Hong Kong dollar — 67,341 Singapore dollar 378 18,025 Australian dollar 278 9,426 Others 26,012 98,113 Total $ 168,410 $ 642,295 We are exposed to credit-related losses in the event of nonperformance by counterparties to financial instruments. These financial instruments include cash deposits and foreign currency forward contracts. We periodically monitor the credit ratings of these counterparties in order to minimize our exposure. Our customers represent a wide variety of industries and geographic regions. For the three and nine months ended July 31, 2023 and 2022, there were no significant concentrations of credit risk. Net Investment Hedges Net assets of our foreign subsidiaries are exposed to volatility in foreign currency exchange rates. We may utilize net investment hedges to offset the translation adjustment arising from re-measuring our investment in foreign subsidiaries. During the second quarter of 2023, the Company designated €180,000 of borrowings as a hedge of our net investment in certain foreign subsidiaries to mitigate the foreign exchange risk associated with certain investments in these subsidiaries. On June 30, 2023, the hedge was terminated. Any increase or decrease related to the remeasurement of the €180,000 borrowing into U.S. dollars was recorded in the currency translation component of Accumulated other comprehensive income (loss) within Shareholders' Equity in the Consolidated Balance Sheet. A gain of $1,144, net of tax, and a loss of $2,467, net of tax, was recorded on these net investment hedges for the three and nine months ended July 31, 2023, respectively. During the quarter ended July 31, 2023, the Company entered into various cross currency swaps between the U.S. Dollar and Euro, Japanese Yen, Taiwan Dollar and Chinese Yuan which were designated as a hedges of our net investments in certain foreign subsidiaries to mitigate the foreign exchange risk associated with certain investments in these subsidiaries. Any increases or decreases related to the remeasurement of the hedges are recorded in the currency translation component of Accumulated other comprehensive income (loss) within Shareholders' Equity in the Consolidated Balance Sheet until the sale or substantial liquidation of the underlying investments. A loss of $1,205, net of tax, was recorded for both the three and nine months ended July 31, 2023. The following table summarizes the fair values of our net investment contracts designated as net investment hedges in the Company's Consolidated Balance Sheets as of July 31, 2023: Prepaid expenses and other current assets Other assets Accrued liabilities Other long-term liabilities Net investment contracts $ 2,977 $ 59 $ 841 $ 3,760

Long-term debt

Long-term debt	9 Months Ended
	Jul. 31, 2023
Debt Disclosure [Abstract]
Long-term debt	Long-term debt A summary of long-term debt is as follows: July 31, 2023 October 31, 2022 Revolving credit agreement, due 2028 $ 200,000 $ — Senior notes, due 2023-2025 32,000 55,500 Senior notes, due 2023-2027 54,286 71,429 Senior notes, due 2023-2030 260,000 350,000 Term loan due 2026 300,000 — Euro Loan — 261,893 846,286 738,822 Less current maturities and notes payable 110,643 392,537 Less unamortized debt issuance costs 8,188 965 Long-term maturities $ 727,455 $ 345,320 Revolving credit agreement, due 2028 — In June 2023, we entered into a $1,150,000 unsecured multi-currency credit facility with a group of banks, which provides for a term loan facility in the aggregate principal amount of $300,000 (the "Term Loan Facility"), maturing in June 2026, and a multicurrency revolving credit facility in the aggregate principal amount of $850,000 (the "Revolving Facility"), maturing in June 2028 (the "New Credit Agreement"). The Company borrowed and has outstanding $300,000 on the Term Loan Facility on June 6, 2023. The Revolving Facility permits borrowing in U.S. Dollars, Euros, Sterling, Swiss Francs, Singapore Dollars, Yen, and each other currency approved by a Revolving Facility lender. The New Credit Agreement provides that the applicable margin for (i) RFR, as defined in the New Credit Agreement, and Eurodollar Loans will range from 0.85% to 1.20% and (ii) Base Rate Loans will range from 0.00% to 0.20%, in each case, based on the Company’s Leverage Ratio (as defined in the Credit Agreement and calculated on a consolidated net debt basis). Borrowings under the New Credit Agreement bear interest at (i) either a base rate or a SOFR rate, with respect to borrowings in U.S. dollars, (ii) a eurocurrency rate, with respect to borrowings in Euros and Yen, or (iii) Daily Simple RFR, with respect to borrowings in Sterling, Swiss Francs or Singapore Dollars, plus, in each case, an applicable margin (and, solely in the case of Singapore Dollars, a spread adjustment). The applicable margin is based on the Company’s Leverage Ratio. The weighted-average interest rate at July 31, 2023 was 6.00%. Revolving credit agreement, due 2024 — In April 2019, we entered into a $850,000 unsecured multi-currency credit facility with a group of banks, which amended, restated and extended our then existing syndicated revolving credit agreement. This facility had a five-year term expiring in April 2024 and included a $75,000 subfacility for swing-line loans. On April 17, 2023, we entered into an amendment to, among other things, replace LIBOR with SOFR, EURIBOR, SONIA and TIBOR for U.S. Dollar, Euro, British Pound Sterling and Japanese Yen borrowings, respectively. On June 6, 2023, this credit agreement was terminated and replaced by the New Credit Agreement. Senior notes, due 2023-2025 — These unsecured fixed-rate notes entered into in 2012 with a group of insurance companies have a remaining weighted-average life of 1.25 years. The weighted-average interest rate at July 31, 2023 was 3.10%. Senior notes, due 2023-2027 — These unsecured fixed-rate notes entered into in 2015 with a group of insurance companies have a remaining weighted-average life of 2.23 years. The weighted-average interest rate at July 31, 2023 was 3.11%. Senior notes, due 2023-2030 — These unsecured fixed-rate notes entered into in 2018 with a group of insurance companies have a remaining weighted-average life of 3.13 years. The weighted-average interest rate at July 31, 2023 was 3.97%. Euro loan — The euro term loan facility with Bank of America Merrill Lynch International Limited was due in March 2023 and was repaid.

Contingencies

Contingencies	9 Months Ended
	Jul. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Contingencies	Contingencies We are involved in pending or potential litigation regarding environmental, product liability, patent, contract, employee and other matters arising from the normal course of business. Including the environmental matters discussed below, after consultation with legal counsel, we do not believe that losses in excess of the amounts we have accrued would have a material adverse effect on our financial condition, quarterly or annual operating results or cash flows. Environmental We have voluntarily agreed with the City of New Richmond, Wisconsin and other potentially responsible parties to share costs associated with the remediation of the City of New Richmond municipal landfill (the Site) and the construction of a potable water delivery system serving the impacted area down gradient of the Site. As of July 31, 2023 and October 31, 2022, our accrual for the ongoing operation, maintenance and monitoring obligation at th e Site was $266 a nd $266, respectively. The liability for environmental remediation represents management’s best estimate of the probable and reasonably estimable undiscounted costs related to known remediation obligations. The accuracy of our estimate of environmental liability is affected by several uncertainties such as additional requirements that may be identified in connection with remedial activities, the complexity and evolution of environmental laws and regulations, and the identification of presently unknown remediation requirements. Consequently, our liability could be greater than our current estimate. However, we do not expect that the costs associated with remediation will have a material adverse effect on our financial condition or results of operations.

Subsequent Events

Subsequent Events	9 Months Ended
	Jul. 31, 2023
Subsequent Events [Abstract]
Subsequent Events	Subsequent Event On August 24, 2023, the Company completed the acquisition of the ARAG Group and its subsidiaries (ARAG Group or ARAG) pursuant to the terms of the Sale and Purchase Agreement, dated as of June 25, 2023, by and among the Company, its Italian subsidiary, Capvis Equity V LP (Capvis), DRIP Co-Investment (DRIP), and certain individuals (the Individual Sellers, and together with Capvis and DRIP, collectively, the Sellers). ARAG is a global market and innovation leader in the development, production and supply of precision control systems and smart fluid components for agricultural spraying. ARAG will operate as a division of our Industrial Precision Solutions segment. In anticipation of the acquisition, the Company entered into a €760,000 senior unsecured term loan facility with a group of banks in August 2023 (the Term F acility ). The Term Facility has a 364-day term and matures in August 2024, and loans under the facility bear interest at a eurocurrency rate plus an applicable margin that will range from 1.1250% to 1.625% based on the Company’s Leverage Ratio (as defined in the term loan credit agreement and calculated on a consolidated net debt basis). The all-cash ARAG acquisition of approximately €957,000, net of the repayment of approximately €30,300 of debt of the acquired companies, was funded using the Term Facility and Revolving Facility. The financial results of the ARAG Group acquisition are not expected to have a material impact on our Consolidated Financial Statements.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Jul. 31, 2023	Apr. 30, 2023	Jan. 31, 2023	Jul. 31, 2022	Apr. 30, 2022	Jan. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Pay vs Performance Disclosure
Net income	$ 127,891	$ 127,563	$ 104,261	$ 141,811	$ 109,634	$ 120,409	$ 359,715	$ 371,854

Insider Trading Arrangements

Insider Trading Arrangements - Stephen P. Lovass [Member]	9 Months Ended
	Jul. 31, 2023 shares
Trading Arrangements, by Individual
Material Terms of Trading Arrangement	On June 30, 2023, Stephen P. Lovass, an Executive Vice President of the Company, adopted a trading arrangement for the sale of the Company’s common shares (a “Rule 10b5-1 Trading Plan”) that is intended to satisfy the affirmative defense conditions of Securities Exchange Act Rule 10b5-1(c). Mr. Lovass’s Rule 10b5-1 Trading Plan, which expires no later than March 28, 2024, provides for the sale of up to 6,898 common shares pursuant to the terms of the Rule 10b5-1 Trading Plan.
Name	Stephen P. Lovass
Title	Executive Vice President of the Company
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	June 30, 2023
Aggregate Available	6,898

Significant accounting polici_2

Significant accounting policies (Policies)	9 Months Ended
	Jul. 31, 2023
Accounting Policies [Abstract]
Basis of presentation	Basis of presentation . The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by generally accepted accounting principles in the United States (U.S. GAAP) for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the nine months ended July 31, 2023 are not necessarily indicative of the results that may be expected for the full year. For further information, refer to the Consolidated Financial Statements and notes
Consolidation	Consolidation.  The Condensed Consolidated Financial Statements include the accounts of Nordson Corporation and its 100%-owned and controlled subsidiaries. Investments in affiliates and joint ventures in which our ownership is 50% or less or in which we do not have control but have the ability to exercise significant influence, are accounted for under the equity method. All significant intercompany accounts and transactions have been eliminated in consolidation.
Use of estimates	Use of estimates . The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect the amounts reported in the Condensed Consolidated Financial Statements. Actual amounts could differ from these estimates.
Revenue recognition	Revenue recognition . A contract exists when it has approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of the consideration is probable. Revenue is recognized when performance obligations under the terms of the contract with a customer are satisfied. Generally, our revenue results from short-term, fixed-price contracts and primarily is recognized as of a point in time when the product is shipped or at a later point when the control of the product transfers to the customer. Revenue for undelivered items is deferred and included within Accrued liabilities in our Consolidated Balance Sheets. Revenues deferred as of July 31, 2023 and 2022 were not material. However, for certain contracts related to the sale of customer-specific products within our Medical and Fluid Solutions segment, revenue is recognized over time as we satisfy performance obligations because of the continuous transfer of control to the customer. The continuous transfer of control to the customer occurs as we enhance assets that are customer controlled and we are contractually entitled to payment for work performed to date plus a reasonable margin. As control transfers over time, revenue is recognized based on progress toward completion of the performance obligations. The selection method to measure progress towards completion requires judgment and is based on the nature of the products or services to be provided. We have elected to use the input method – costs incurred for these contracts because it best depicts the transfer of products or services to the customer based on incurring costs on the contract. Under this method, revenues are recorded proportionally as costs are incurred. Contract assets recognized are recorded in Prepaid expenses and other current assets and contract liabilities are recorded in Accrued liabilities in our Consolidated Balance Sheets and were not material on July 31, 2023 and October 31, 2022. Revenue recognized over time represented approximately less than ten percent of our overall consolidated revenues at July 31, 2023 and October 31, 2022. Revenue is measured as the amount of consideration we expect to receive in exchange for transferring products or services. Taxes, including sales and value add, that we collect concurrently with revenue-producing activities are excluded from revenue. As a practical expedient, we may exclude the assessment of whether goods or services are performance obligations, if they are immaterial in the context of the contract, and combine these with other performance obligations. While payment terms and conditions vary by contract type, we have determined that our contracts generally do not include a significant financing component. We have elected to apply the practical expedient to treat all shipping and handling costs as fulfillment costs as a significant portion of these costs are incurred prior to transfer of control to the customer. We have also elected to apply the practical expedient to expense sales commissions as they are incurred as the amortization period resulting from capitalizing the costs is one year or less. These costs are recorded within Selling and administrative expenses in our Condensed Consolidated Statements of Income. We offer assurance-type warranties on our products as well as separately sold warranty contracts. Revenue related to warranty contracts that are sold separately is recognized over the life of the warranty term and are not material. Certain arrangements may include installation, installation supervision, training, and spare parts, which tend to be completed in a short period of time, at an insignificant cost, and utilizing skills not unique to us, and, therefore, these items are typically regarded as inconsequential or not material. We disclose disaggregated revenues by operating segment and geography in accordance with the revenue standard and on the same basis used internally by the chief operating decision maker for evaluating performance of operating segments and for allocating resources. Refer to our Operating segments Note for details.
Earnings per share	Earnings per share . Basic earnings per share are computed based on the weighted-average number of common shares outstanding during each year, while diluted earnings per share are based on the weighted-average number of common shares and common share equivalents outstanding. Common share equivalents consist of shares issuable upon exercise of stock options computed using the treasury stock method, as well as restricted shares and deferred stock-based compensation. Options whose exercise price is higher than the average market price are excluded from the calculation of diluted earnings per share because the effect would be anti-dilutive. Options excluded from the calculation of diluted earnings per share for the three months ended July 31, 2023 and 2022 were 138 and 76, respectively. Options excluded from the calculation of diluted earnings per share for the nine months ended July 31, 2023 and 2022 were 141 and 79, respectively.
Recently issued accounting standards	There have been no new accounting standards issued which would require either disclosure or adoption during the current periods.

Business Combinations and Asset

Business Combinations and Asset Acquisitions (Tables)	Nov. 03, 2022
Business Combination and Asset Acquisition [Abstract]
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed	The assets and liabilities acquired were as follows: November 3, 2022 Cash $ 40,890 Receivables - net 21,364 Inventories - net 35,300 Goodwill 279,630 Intangibles 58,600 Other assets 14,046 Total Assets $ 449,830 Accounts payable $ 8,109 Deferred income taxes 14,294 Other liabilities 8,694 Total Liabilities $ 31,097

Inventories (Tables)

Inventories (Tables)	9 Months Ended
	Jul. 31, 2023
Inventory Disclosure [Abstract]
Schedule of Inventories	Components of inventories were as follows: July 31, 2023 October 31, 2022 Finished goods $ 234,690 $ 218,491 Raw materials and component parts 200,475 157,447 Work-in-process 62,856 53,195 498,021 429,133 Obsolescence and other reserves (58,280) (45,735) $ 439,741 $ 383,398

Property, Plant and Equipment (

Property, Plant and Equipment (Tables)	9 Months Ended
	Jul. 31, 2023
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment	Components of property, plant and equipment were as follows: July 31, 2023 October 31, 2022 Land $ 9,856 $ 9,278 Land improvements 5,033 4,979 Buildings 282,260 271,450 Machinery and equipment 536,215 505,343 Enterprise management system 52,938 52,513 Construction-in-progress 20,130 31,466 Leased property under finance leases 28,047 27,512 934,479 902,541 Accumulated depreciation and amortization (583,744) (549,099) $ 350,735 $ 353,442

Goodwill and other intangible_2

Goodwill and other intangible assets (Tables)	9 Months Ended
	Jul. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Summary of Changes in Carrying Amount of Goodwill	Changes in the carrying amount of goodwill for th e nine months ended July 31, 2023 by operating segment were as follows: Industrial Medical Fluid Systems Advanced Total Balance at October 31, 2022 $ 520,236 $ 1,172,069 $ 112,388 $ 1,804,693 Acquisitions — — 279,630 279,630 Currency effect 4,744 3,869 17,844 26,457 Balance at July 31, 2023 $ 524,980 $ 1,175,938 $ 409,862 $ 2,110,780
Summary of Intangible Assets Subject to Amortization	Information regarding our intangible assets subject to amortization was as follows: July 31, 2023 Carrying Accumulated Net Book Customer relationships $ 517,147 $ 282,598 $ 234,549 Patent/technology costs 176,396 109,783 66,613 Trade name 99,413 50,673 48,740 Non-compete agreements 10,559 9,937 622 Other 143 143 — Total $ 803,658 $ 453,134 $ 350,524 October 31, 2022 Carrying Accumulated Net Book Customer relationships $ 480,058 $ 250,798 $ 229,260 Patent/technology costs 157,549 96,426 61,123 Trade name 82,759 44,707 38,052 Non-compete agreements 10,253 9,290 963 Other 446 442 4 Total $ 731,065 $ 401,663 $ 329,402

Pension and other postretirem_2

Pension and other postretirement plans (Tables)	9 Months Ended
	Jul. 31, 2023
Retirement Benefits [Abstract]
Components of Net Periodic Benefits Cost	The components of net periodic pension and other postretirement cost for the three and nine months ended July 31, 2023 and 2022 were: U.S. International Three Months Ended 2023 2022 2023 2022 Service cost $ 2,744 $ 3,423 $ 281 $ 423 Interest cost 4,176 3,322 642 272 Expected return on plan assets (6,529) (5,692) (392) (347) Amortization of prior service cost (credit) — 12 (13) (13) Amortization of net actuarial loss — 1,197 20 558 Total benefit cost $ 391 $ 2,262 $ 538 $ 893 U.S. International Nine Months Ended 2023 2022 2023 2022 Service cost $ 8,233 $ 13,338 $ 838 $ 1,343 Interest cost 12,526 11,146 1,887 861 Expected return on plan assets (19,587) (22,082) (1,151) (1,109) Amortization of prior service cost (credit) — 36 (38) (43) Amortization of net actuarial loss — 6,282 61 1,758 Settlement loss — 41,221 — — Total benefit cost $ 1,172 $ 49,941 $ 1,597 $ 2,810 The components of other postretirement benefit costs for the three and nine months ended July 31, 2023 and 2022 were: U.S. International Three Months Ended 2023 2022 2023 2022 Service cost $ 100 $ 172 $ 1 $ 3 Interest cost 766 481 3 3 Amortization of net actuarial (gain) loss — 244 (16) (12) Total benefit cost (income) $ 866 $ 897 $ (12) $ (6) U.S. International Nine Months Ended 2023 2022 2023 2022 Service cost $ 299 $ 515 $ 4 $ 9 Interest cost 2,297 1,443 8 10 Amortization of net actuarial (gain) loss — 733 (47) (37) Total benefit cost (income) $ 2,596 $ 2,691 $ (35) $ (18)

Accumulated other comprehensi_2

Accumulated other comprehensive loss (Tables)	9 Months Ended
	Jul. 31, 2023
Equity [Abstract]
Summary of Accumulated Other Comprehensive Loss	The components of accumulated other comprehensive income (loss), including adjustments for items that are reclassified from accumulated other comprehensive loss to net income, are shown below. Cumulative Pension and Accumulated Balance at October 31, 2022 $ (160,046) $ (47,736) $ (207,782) Pension and other postretirement plan adjustments, net of tax of ($305) — (908) (908) Foreign currency translation adjustments (a) 79,986 — 79,986 Balance at July 31, 2023 $ (80,060) $ (48,644) $ (128,704) (a) Includes a net loss of $3,672, net of tax of $1,097, on net investment hedges.

Stock-based compensation (Table

Stock-based compensation (Tables)	9 Months Ended
	Jul. 31, 2023
Share-Based Payment Arrangement [Abstract]
Summarized Activity Related to Stock Options	The following table summarizes activity related to stock options for the nine months ended July 31, 2023: Number of Weighted- Aggregate Weighted Outstanding at October 31, 2022 1,187 $ 141.82 Granted 80 239.44 Exercised (163) 115.67 Forfeited or expired (10) 206.93 Outstanding at July 31, 2023 1,094 $ 151.09 $ 111,165 5.1 years Expected to vest 245 $ 214.42 $ 10,006 7.5 years Exercisable at July 31, 2023 846 $ 132.58 $ 101,014 4.4 years
Fair Value Assumptions of Stock Options	The fair value of each option grant was estimated at the date of grant using the Black-Scholes option-pricing model with the following assumptions: Nine Months Ended July 31, 2023 July 31, 2022 Expected volatility 30.4% - 31.8% 30.6% - 30.8% Expected dividend yield 1.12% - 1.27% 0.76% - 0.76% Risk-free interest rate 3.79% - 4.21% 1.36% - 1.47% Expected life of the option (in years) 5.0 - 6.2 5.3 - 6.2
Summarized Activity Related to Restricted Stock	The following table summarizes activity related to restricted shares during the nine months ended July 31, 2023: Number of Shares Weighted-Average Restricted shares at October 31, 2022 6 $ 167.99 Vested (6) 167.99 Restricted shares at July 31, 2023 — $ —
Summarized Activity Related to Restricted Stock Units	The following table summarizes activity related to restricted share units during the nine months ended July 31, 2023: Number of Units Weighted-Average Restricted share units at October 31, 2022 81 $ 223.77 Granted 39 237.18 Forfeited (5) 241.37 Vested (45) 219.06 Restricted share units at July 31, 2023 70 $ 232.88
Summarized Activity Related to Director Deferred Compensation Shares	The following table summarizes activity related to director deferred compensation share equivalent units during the nine months ended July 31, 2023: Number of Shares Weighted-Average Outstanding at October 31, 2022 90 $ 77.70 Distributions (13) 52.50 Outstanding at July 31, 2023 78 $ 84.02

Warranties (Tables)

Warranties (Tables)	9 Months Ended
	Jul. 31, 2023
Guarantees [Abstract]
Reconciliation of Product Warranty Liability	Following is a reconciliation of the product warranty liability for the nine months ended July 31, 2023 and 2022: July 31, 2023 July 31, 2022 Beginning balance at October 31 $ 11,723 $ 11,113 Accruals for warranties 14,938 12,496 Warranty payments (12,939) (10,704) Currency effect 566 (676) Ending balance $ 14,288 $ 12,229

Operating segments (Tables)

Operating segments (Tables)	9 Months Ended
	Jul. 31, 2023
Segment Reporting [Abstract]
Schedule of Segments	The following table presents information about our segments: Three Months Ended Industrial Medical and Fluid Solutions Advanced Corporate Total July 31, 2023 Net external sales $ 338,257 $ 170,871 $ 139,549 $ — $ 648,677 Operating profit (loss) 115,346 54,019 27,083 (25,452) 170,996 July 31, 2022 Net external sales $ 341,215 $ 177,840 $ 143,073 $ — $ 662,128 Operating profit (loss) 119,706 58,103 28,155 (21,046) 184,918 Nine Months Ended July 31, 2023 Net external sales $ 985,610 $ 491,683 $ 432,026 $ — $ 1,909,319 Operating profit (loss) 329,439 141,326 70,136 (53,179) 487,722 July 31, 2022 Net external sales $ 981,582 $ 508,836 $ 416,279 $ — $ 1,906,697 Operating profit (loss) 324,089 165,510 95,533 (60,381) 524,751
Sales and Long-lived Asset Information by Geographic Regions	We had significant sales in the following geographic regions: Three Months Ended Nine Months Ended July 31, 2023 July 31, 2022 July 31, 2023 July 31, 2022 Americas $ 290,515 $ 279,205 $ 834,125 $ 792,859 Europe 167,536 151,659 498,379 479,900 Asia Pacific 190,626 231,264 576,815 633,938 Total net external sales $ 648,677 $ 662,128 $ 1,909,319 $ 1,906,697

Fair value measurements (Tables

Fair value measurements (Tables)	9 Months Ended
	Jul. 31, 2023
Fair Value Disclosures [Abstract]
Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis	The following tables present the classification of our assets and liabilities measured at fair value on a recurring basis: July 31, 2023 Total Level 1 Level 2 Level 3 Assets: Foreign currency forward contracts (a) $ 9,608 $ — $ 9,608 $ — Net investment contracts (b) 3,036 — 3,036 — Total assets at fair value $ 12,644 $ — $ 12,644 $ — Liabilities: Deferred compensation plans (c) $ 10,636 $ — $ 10,636 $ — Foreign currency forward contracts (a) 4,209 — 4,209 — Net investment contracts (b) 4,601 — 4,601 — Total liabilities at fair value $ 19,446 $ — $ 19,446 $ — October 31, 2022 Total Level 1 Level 2 Level 3 Assets: Foreign currency forward contracts (a) $ 5,035 $ — $ 5,035 $ — Total assets at fair value $ 5,035 $ — $ 5,035 $ — Liabilities: Deferred compensation plans (b) $ 9,076 $ — $ 9,076 $ — Foreign currency forward contracts (a) 11,724 — 11,724 — Total liabilities at fair value $ 20,800 $ — $ 20,800 $ — (a) We enter into foreign currency forward contracts to reduce the risk of foreign currency exposures resulting from receivables, payables, intercompany receivables, intercompany payables and loans denominated in foreign currencies. Foreign exchange contracts are valued using market exchange rates. These foreign exchange contracts are not designated as hedges. (b) Net assets of our foreign subsidiaries are exposed to volatility in foreign currency exchange rates. We utilize net investment hedges to offset the translation adjustment arising from re-measuring our investment in foreign subsidiaries. The notional amount of our net investment hedge contracts as of July 31, 2023 was $385,000. (c) Executive officers and other highly compensated employees may defer up to 100% of their salary and annual cash incentive compensation and for executive officers, up to 90% of their long-term incentive compensation, into various non-qualified deferred compensation plans. Deferrals can be allocated to various market performance measurement funds. Changes in the value of compensation deferred under these plans are recognized each period based on the fair value of the underlying measurement funds.
Carrying Amounts and Fair Values of Financial Instruments, Other than Cash and Cash Equivalents, Receivables and Accounts Payable	The carrying values of cash and cash equivalents, receivables and accounts payable approximate fair value due to the short-term nature of these instruments. July 31, 2023 Carrying Amount Fair Value Long-term debt (including current portion) $ 838,098 $ 836,098

Derivative financial instrume_2

Derivative financial instruments (Tables) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Jul. 31, 2023	Jul. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Outstanding Currency, Forward Exchange Contracts		The following table summarizes, by currency, the foreign currency forward contracts outstanding at July 31, 2023 and 2022: July 31, 2023 contract amounts: Notional Sell Amounts Notional Buy Amounts Euro $ 95,064 $ 194,850 British pound 20,489 132,956 Japanese yen 23,195 17,908 Mexican Peso 3,227 28,158 Hong Kong dollar 2,080 7,265 Singapore dollar 60 19,817 Australian dollar — 9,236 Taiwan Dollar — 8,000 Others 2,602 71,830 Total $ 146,717 $ 490,020 July 31, 2022 contract amounts: Notional Sell Amounts Notional Buy Amounts Euro $ 88,275 $ 333,285 British pound 36,779 78,942 Japanese yen 16,688 37,163 Hong Kong dollar — 67,341 Singapore dollar 378 18,025 Australian dollar 278 9,426 Others 26,012 98,113 Total $ 168,410 $ 642,295
Schedule of Fair Value Hedging Instruments, Statements of Financial Performance and Financial Position, Location		The following table summarizes the fair values of our net investment contracts designated as net investment hedges in the Company's Consolidated Balance Sheets as of July 31, 2023: Prepaid expenses and other current assets Other assets Accrued liabilities Other long-term liabilities Net investment contracts $ 2,977 $ 59 $ 841 $ 3,760
Net Investment Hedge Gain (Loss)		$ (1,205)
Other Comprehensive Income (Loss), Net Investment Hedge, Net of Tax	$ 1,144	$ (2,467)

Long-term debt (Tables)

Long-term debt (Tables)	9 Months Ended
	Jul. 31, 2023
Debt Disclosure [Abstract]
Long-Term Debt	A summary of long-term debt is as follows: July 31, 2023 October 31, 2022 Revolving credit agreement, due 2028 $ 200,000 $ — Senior notes, due 2023-2025 32,000 55,500 Senior notes, due 2023-2027 54,286 71,429 Senior notes, due 2023-2030 260,000 350,000 Term loan due 2026 300,000 — Euro Loan — 261,893 846,286 738,822 Less current maturities and notes payable 110,643 392,537 Less unamortized debt issuance costs 8,188 965 Long-term maturities $ 727,455 $ 345,320

Significant accounting polici_3

Significant accounting policies - Additional Information (Detail) - shares shares in Thousands	3 Months Ended		9 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Significant Accounting Policies [Line Items]
Less than 50% Ownership Percentage, Accounted for under the Equity Method of Investment	50%		50%
Stock Options
Significant Accounting Policies [Line Items]
Options for common shares excluded from computation of diluted earning per share (in shares)	138	76	141	79

Acquisitions - Narrative (Detai

Acquisitions - Narrative (Detail) - USD ($) $ in Thousands			9 Months Ended
	Nov. 03, 2022	Nov. 01, 2021	Jul. 31, 2023	Jul. 31, 2022	Oct. 31, 2022
Business Acquisition [Line Items]
Acquisition of businesses, net of cash acquired			$ 377,843	$ 171,613
Goodwill			$ 2,110,780		$ 1,804,693
NDC
Business Acquisition [Line Items]
Acquired percent of the outstanding shares		100%
Acquisition of businesses, net of cash acquired		$ 171,613
Cash		7,533
Goodwill		131,129
Intangibles		31,130
Other working capital adjustments		2,763
Goodwill, expected tax deductible amount		72,018
NDC | Trade name
Business Acquisition [Line Items]
Intangibles		$ 10,800
Intangible assets amortization period		13 years
NDC | Technology-Based Intangible Assets
Business Acquisition [Line Items]
Intangibles		$ 10,000
Intangible assets amortization period		7 years
NDC | Customer relationships
Business Acquisition [Line Items]
Intangibles		$ 9,500
Intangible assets amortization period		4 years
NDC | Non-compete agreements
Business Acquisition [Line Items]
Intangibles		$ 830
Intangible assets amortization period		3 years
CyberOptics Corporation
Business Acquisition [Line Items]
Acquired percent of the outstanding shares	100%
Acquisition of businesses, net of cash acquired	$ 377,843
Cash	40,890
Goodwill	279,630
Intangibles	58,600
CyberOptics Corporation | Trade name
Business Acquisition [Line Items]
Intangibles	$ 15,200
Intangible assets amortization period	15 years
CyberOptics Corporation | Technology-Based Intangible Assets
Business Acquisition [Line Items]
Intangibles	$ 14,600
Intangible assets amortization period	7 years
CyberOptics Corporation | Customer relationships
Business Acquisition [Line Items]
Intangibles	$ 28,800
Intangible assets amortization period	12 years

Acquisitions - Schedule of Reco

Acquisitions - Schedule of Recognized Identified Assets Acquired and Liabilities Assumed (Details) - USD ($) $ in Thousands	Nov. 03, 2022	Jul. 31, 2023	Oct. 31, 2022
Business Acquisition [Line Items]
Goodwill		$ 2,110,780	$ 1,804,693
CyberOptics Corporation
Business Acquisition [Line Items]
Cash	$ 40,890
Receivables - net	21,364
Inventories - net	35,300
Goodwill	279,630
Intangibles	58,600
Other assets	14,046
Total Assets	449,830
Accounts payable	8,109
Deferred income taxes	14,294
Other liabilities	8,694
Total Liabilities	$ 31,097

Receivables (Details)

Receivables (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022	Oct. 31, 2022
Credit Loss [Abstract]
Accounts receivable, after allowance for credit loss	$ 8,076		$ 8,076		$ 8,218
Provisions for losses on receivables	$ 410	$ 788	$ (239)	$ 1,439

Inventories - Schedule of Inven

Inventories - Schedule of Inventories (Detail) - USD ($) $ in Thousands	Jul. 31, 2023	Oct. 31, 2022
Inventory Disclosure [Abstract]
Finished goods	$ 234,690	$ 218,491
Raw materials and component parts	200,475	157,447
Work-in-process	62,856	53,195
Inventories - gross	498,021	429,133
Obsolescence and other reserves	(58,280)	(45,735)
Inventories - net	$ 439,741	$ 383,398

Property, Plant and Equipment_2

Property, Plant and Equipment (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022	Oct. 31, 2022
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 934,479		$ 934,479		$ 902,541
Accumulated depreciation and amortization	(583,744)		(583,744)		(549,099)
Property, plant and equipment - net	350,735		350,735		353,442
Depreciation	13,180	$ 12,178	38,798	$ 36,876
Land
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	9,856		9,856		9,278
Land improvements
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	5,033		5,033		4,979
Buildings
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	282,260		282,260		271,450
Machinery and equipment
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	536,215		536,215		505,343
Enterprise management system
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	52,938		52,938		52,513
Construction-in-progress
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	20,130		20,130		31,466
Leased property under finance leases
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 28,047		$ 28,047		$ 27,512

Goodwill and other intangible_3

Goodwill and other intangible assets - Summary of Changes in Carrying Amount of Goodwill (Detail) $ in Thousands	9 Months Ended
	Jul. 31, 2023 USD ($)
Goodwill [Roll Forward]
Beginning balance	$ 1,804,693
Acquisitions	279,630
Currency effect	26,457
Ending balance	2,110,780
Industrial Precision Solutions
Goodwill [Roll Forward]
Beginning balance	520,236
Acquisitions	0
Currency effect	4,744
Ending balance	524,980
Advanced Technology Solutions
Goodwill [Roll Forward]
Beginning balance	112,388
Acquisitions	279,630
Currency effect	17,844
Ending balance	409,862
Medical Fluid Systems
Goodwill [Roll Forward]
Beginning balance	1,172,069
Acquisitions	0
Currency effect	3,869
Ending balance	$ 1,175,938

Goodwill and other intangible_4

Goodwill and other intangible assets - Summary of Intangible Assets Subject to Amortization (Detail) - USD ($) $ in Thousands	Jul. 31, 2023	Oct. 31, 2022
Finite-Lived Intangible Assets [Line Items]
Carrying  Amount	$ 803,658	$ 731,065
Accumulated Amortization	453,134	401,663
Net Book  Value	350,524	329,402
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Carrying  Amount	517,147	480,058
Accumulated Amortization	282,598	250,798
Net Book  Value	234,549	229,260
Patent/technology costs
Finite-Lived Intangible Assets [Line Items]
Carrying  Amount	176,396	157,549
Accumulated Amortization	109,783	96,426
Net Book  Value	66,613	61,123
Trade name
Finite-Lived Intangible Assets [Line Items]
Carrying  Amount	99,413	82,759
Accumulated Amortization	50,673	44,707
Net Book  Value	48,740	38,052
Non-compete agreements
Finite-Lived Intangible Assets [Line Items]
Carrying  Amount	10,559	10,253
Accumulated Amortization	9,937	9,290
Net Book  Value	622	963
Other
Finite-Lived Intangible Assets [Line Items]
Carrying  Amount	143	446
Accumulated Amortization	143	442
Net Book  Value	$ 0	$ 4

Goodwill and other intangible_5

Goodwill and other intangible assets - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible assets, amortization expense	$ 13,922	$ 12,709	$ 41,839	$ 38,366

Pension and other postretirem_3

Pension and other postretirement plans - Additional Information (Details) $ in Thousands	Jul. 31, 2022 USD ($) segment
Retirement Benefits [Abstract]
Defined benefit plan, plan assets, amount | $	$ 171,181
Number of retirees and other beneficiaries | segment	1,500

Pension and other postretirem_4

Pension and other postretirement plans - Net Periodic Benefit Cost (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Pension Plans | International
Defined Benefit Plan Disclosure [Line Items]
Service cost	$ 281	$ 423	$ 838	$ 1,343
Interest cost	642	272	1,887	861
Expected return on plan assets	(392)	(347)	(1,151)	(1,109)
Amortization of prior service cost (credit)	(13)	(13)	(38)	(43)
Amortization of net actuarial (gain) loss	20	558	61	1,758
Total benefit cost	538	893	1,597	2,810
Settlement loss			0	0
Pension Plans | United States
Defined Benefit Plan Disclosure [Line Items]
Service cost	2,744	3,423	8,233	13,338
Interest cost	4,176	3,322	12,526	11,146
Expected return on plan assets	(6,529)	(5,692)	(19,587)	(22,082)
Amortization of prior service cost (credit)	0	12	0	36
Amortization of net actuarial (gain) loss	0	1,197	0	6,282
Total benefit cost	391	2,262	1,172	49,941
Settlement loss			0	(41,221)
Postretirement Benefit Costs | International
Defined Benefit Plan Disclosure [Line Items]
Service cost	1	3	4	9
Interest cost	3	3	8	10
Amortization of net actuarial (gain) loss	(16)	(12)	(47)	(37)
Total benefit cost	(12)	(6)	(35)	(18)
Postretirement Benefit Costs | United States
Defined Benefit Plan Disclosure [Line Items]
Service cost	100	172	299	515
Interest cost	766	481	2,297	1,443
Amortization of net actuarial (gain) loss	0	244	0	733
Total benefit cost	$ 866	$ 897	$ 2,596	$ 2,691

Income taxes (Detail)

Income taxes (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Income Tax Disclosure [Abstract]
Effective tax rates	21.10%	21.40%	20.90%	21.20%
Income tax provision included discrete tax benefit due to share-based payment transactions	$ 996	$ 115	$ 2,745	$ 1,539

Accumulated other comprehensi_3

Accumulated other comprehensive loss - Summary of Accumulated Other Comprehensive Loss (Detail) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Jul. 31, 2023	Apr. 30, 2023	Jan. 31, 2023	Jul. 31, 2022	Apr. 30, 2022	Jan. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	$ 2,497,002	$ 2,446,685	$ 2,294,375	$ 2,190,616	$ 2,218,628	$ 2,159,130	$ 2,294,375	$ 2,159,130
Pension and other postretirement plan adjustments, net of tax of ($305)	(159)			1,848			(908)	7,686
Foreign currency translation adjustments (a)	3,455	(290)	76,821	(21,220)	(46,901)	(13,358)	79,986	(81,479)
Ending balance	2,579,806	2,497,002	2,446,685	2,199,045	2,190,616	2,218,628	2,579,806	2,199,045
Amortization of prior service costs and net actuarial losses, tax							305
Other Comprehensive Income (Loss), Net Investment Hedge, Tax							1,097
Other Comprehensive Income (Loss), Net Investment Hedge, Net of Tax	1,144						(2,467)
Other Comprehensive Income (Loss), Net Investment Hedge, Gross							(3,672)
Accumulated Other Comprehensive Income (Loss)
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(132,000)	(131,537)	(207,782)	(198,209)	(186,133)	(175,835)	(207,782)	(175,835)
Foreign currency translation adjustments (a)	3,455	(290)	76,821	(21,220)	(46,901)	(13,358)
Ending balance	(128,704)	$ (132,000)	(131,537)	$ (217,581)	$ (198,209)	$ (186,133)	(128,704)	$ (217,581)
Cumulative translation adjustments
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance			(160,046)				(160,046)
Pension and other postretirement plan adjustments, net of tax of ($305)							0
Foreign currency translation adjustments (a)							79,986
Ending balance	(80,060)						(80,060)
Pension and postretirement  benefit plan adjustments
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance			$ (47,736)				(47,736)
Pension and other postretirement plan adjustments, net of tax of ($305)							(908)
Foreign currency translation adjustments (a)							0
Ending balance	$ (48,644)						$ (48,644)

Stock-based compensation - Addi

Stock-based compensation - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022	Oct. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Maximum number of common shares authorized for grant (in shares)	900,000		900,000
Number of common shares available for grant (in shares)	2,012,000		2,012,000
Executive officers and other highly compensated employees salary and annual cash incentive compensation deferrals percentage, maximum			100%
Executive officers share-based long-term incentive compensation deferrals percentage, maximum			90%
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Option expiring period			10 years
Normal retirement age			65 years
Period for options considered to be forfeited for retirees			12 months
Termination period on death or disability of option holder			12 months
Compensation expense recognized	$ 1,697	$ 1,580	$ 4,982	$ 5,743
Unrecognized compensation cost related to unvested stock option	7,013		$ 7,013
Weighted average period expected to be amortized, non vested shares			1 year 8 months 12 days
Weighted-average expected volatility used			30.60%	30.60%
Weighted average grant date fair value of stock options granted (in dollars per share)			$ 77.99	$ 79.03
Total intrinsic value of options exercised	7,741	1,052	$ 19,873	$ 10,418
Cash received from the exercise of stock options			$ 18,449	8,845
Stock Options | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Maximum rate of stock option			25%
Restricted Shares and Restricted Share Units | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant restricted shares transferred period			3 years
Restricted Shares and Restricted Share Units | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant restricted shares transferred period			1 year
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Normal retirement age			65 years
Period for restricted shares and share units considered to be forfeited for retirees			12 months
Restricted shares termination period for disability or death			12 months
Unrecognized compensation cost related to nonvested restricted stock	0		$ 0
Expense related to nonvested common shares	73	243	336	856
Common share dividends amount included in compensation cost	$ 2	4	$ 5	14
Weighted average grant date fair value (in dollars per share)	$ 0		$ 0		$ 167.99
Restricted Stock Unit
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average period expected to be amortized, non vested shares			1 year 9 months 18 days
Unrecognized compensation cost related to nonvested restricted stock	$ 10,080		$ 10,080
Expense related to nonvested common shares	$ 2,152	2,154	$ 6,658	6,246
Weighted average grant date fair value (in dollars per share)	$ 232.88		$ 232.88		$ 223,770
Performance Share Incentive Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award requisite service period			3 years
Compensation expense	$ 1,831	$ 3,555	$ 4,785	$ 10,296
Unrecognized compensation cost	$ 7,947		$ 7,947
Performance Share Incentive Awards | Grant Date One
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average grant date fair value (in dollars per share)	$ 231.34	$ 273.50	$ 231.34	$ 273.50
Performance Share Incentive Awards | Grant Date Two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average grant date fair value (in dollars per share)	211.25	260.60	211.25	260.60
Performance Share Incentive Awards | Grant Date Three
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average grant date fair value (in dollars per share)	$ 214.51	$ 221.94	$ 214.51	$ 221.94
Deferred Compensation
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common share dividends amount included in compensation cost	$ 30	$ 17	$ 77	$ 53
Executive officers and other highly compensated employees salary and annual cash incentive compensation deferrals percentage, maximum			100%
Executive officers share-based long-term incentive compensation deferrals percentage, maximum			90%
Deferred Compensation | Directors
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expense related to director deferred compensation	$ 76	$ 73	$ 234	$ 224

Stock-based compensation - Summ

Stock-based compensation - Summarized Activity Related to Stock Options (Detail) - Stock Options $ / shares in Units, shares in Thousands, $ in Thousands	9 Months Ended
	Jul. 31, 2023 USD ($) $ / shares shares
Number of Options
Beginning balance (in shares) | shares	1,187
Granted (in shares) | shares	80
Exercised (in shares) | shares	(163)
Forfeited or expired (in shares) | shares	(10)
Ending balance (in shares) | shares	1,094
Expected to vest (in shares) | shares	245
Exercisable (in shares) | shares	846
Weighted- Average Exercise Price  Per Share
Beginning balance (in dollars per share) | $ / shares	$ 141.82
Granted (in dollars per share) | $ / shares	239.44
Exercised (in dollars per share) | $ / shares	115.67
Forfeited or expired (in dollars per share) | $ / shares	206.93
Ending balance (in dollars per share) | $ / shares	151.09
Expected to vest (in dollars per share) | $ / shares	214.42
Exercisable (in dollars per share) | $ / shares	$ 132.58
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Aggregate intrinsic value, outstanding | $	$ 111,165
Aggregate intrinsic value, expected to vest | $	10,006
Aggregate intrinsic value, exercisable | $	$ 101,014
Weighted average remaining term, outstanding	5 years 1 month 6 days
Weighted average remaining term, expected to vest	7 years 6 months
Weighted average remaining term, exercisable	4 years 4 months 24 days

Stock-based compensation - Fair

Stock-based compensation - Fair Value Assumptions of Stock Options (Detail) - Stock Options	9 Months Ended
	Jul. 31, 2023	Jul. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected volatility, minimum	30.40%	30.60%
Expected volatility, maximum	31.80%	30.80%
Risk-free interest rate, minimum	3.79%	1.36%
Risk-free interest rate, maximum	4.21%	1.47%
Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected dividend yield	1.12%	0.76%
Expected life of the option (in years)	5 years	5 years 3 months 18 days
Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected dividend yield	1.27%	0.76%
Expected life of the option (in years)	6 years 2 months 12 days	6 years 2 months 12 days

Stock-based compensation - Su_2

Stock-based compensation - Summarized Activity Related to Restricted Stock (Detail) - Restricted Stock shares in Thousands	9 Months Ended
	Jul. 31, 2023 $ / shares shares
Number of Shares
Beginning balance (in shares) | shares	6
Vested (in shares) | shares	(6)
Ending balance (in shares) | shares	0
Weighted-Average Grant Date Fair Value
Beginning balance (in dollars per share) | $ / shares	$ 167.99
Vested (in dollars per share) | $ / shares	167.99
Ending balance (in dollars per share) | $ / shares	$ 0

Stock-based compensation - Su_3

Stock-based compensation - Summarized Activity Related to Restricted Stock Units (Detail) - Restricted Stock Unit shares in Thousands	9 Months Ended
	Jul. 31, 2023 $ / shares shares
Number of Shares
Beginning balance (in shares) | shares	81
Granted (in shares) | shares	39
Forfeited (in shares) | shares	(5)
Vested (in shares) | shares	(45)
Ending balance (in shares) | shares	70
Weighted-Average Grant Date Fair Value
Beginning balance (in dollars per share) | $ / shares	$ 223,770
Granted (in dollars per share) | $ / shares	237.18
Forfeited (in dollars per share) | $ / shares	241.37
Vested (in dollars per share) | $ / shares	219.06
Ending balance (in dollars per share) | $ / shares	$ 232.88

Stock-based compensation - Su_4

Stock-based compensation - Summarized Activity Related to Director Deferred Compensation Shares (Detail) - Directors - Deferred Compensation Share Equivalent Units shares in Thousands	9 Months Ended
	Jul. 31, 2023 $ / shares shares
Number of Shares
Outstanding, Beginning balance (in shares) | shares	90
Distributions (in shares) | shares	(13)
Outstanding, Ending balance (in shares) | shares	78
Weighted-Average Grant Date Fair Value
Beginning balance (in dollars per share) | $ / shares	$ 77.70
Distributions (in dollars per share) | $ / shares	52.50
Ending balance (in dollars per share) | $ / shares	$ 84.02

Warranties - Additional Informa

Warranties - Additional Information (Detail)	9 Months Ended
	Jul. 31, 2023
Guarantees [Abstract]
Product warranty period	1 year

Warranties - Reconciliation of

Warranties - Reconciliation of Product Warranty Liability (Detail) - USD ($) $ in Thousands	9 Months Ended
	Jul. 31, 2023	Jul. 31, 2022
Movement in Standard and Extended Product Warranty Accrual, Increase (Decrease) [Roll Forward]
Beginning balance	$ 11,723	$ 11,113
Accruals for warranties	14,938	12,496
Warranty payments	(12,939)	(10,704)
Currency effect	566	(676)
Ending balance	$ 14,288	$ 12,229

Operating segments - Additional

Operating segments - Additional Information (Detail)	9 Months Ended
	Jul. 31, 2023 segment
Segment Reporting [Abstract]
Number of operating segments	3

Operating segments - Segments (

Operating segments - Segments (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Segment Reporting Information [Line Items]
Net external sales	$ 648,677	$ 662,128	$ 1,909,319	$ 1,906,697
Operating profit (loss)	170,996	184,918	487,722	524,751
Operating Segments
Segment Reporting Information [Line Items]
Net external sales	648,677	662,128	1,909,319	1,906,697
Operating profit (loss)	170,996	184,918	487,722	524,751
Operating Segments | Industrial Precision Solutions
Segment Reporting Information [Line Items]
Net external sales	338,257	341,215	985,610	981,582
Operating profit (loss)	115,346	119,706	329,439	324,089
Operating Segments | Advanced Technology Solutions
Segment Reporting Information [Line Items]
Net external sales	139,549	143,073	432,026	416,279
Operating profit (loss)	27,083	28,155	70,136	95,533
Operating Segments | Medical and Fluid Solutions
Segment Reporting Information [Line Items]
Net external sales	170,871	177,840	491,683	508,836
Operating profit (loss)	54,019	58,103	141,326	165,510
Corporate
Segment Reporting Information [Line Items]
Net external sales	0	0	0	0
Operating profit (loss)	$ (25,452)	$ (21,046)	$ (53,179)	$ (60,381)

Operating segments - Sales Info

Operating segments - Sales Information by Geographic Regions (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Revenues from External Customers and Long-Lived Assets [Line Items]
Net external sales	$ 648,677	$ 662,128	$ 1,909,319	$ 1,906,697
Americas
Revenues from External Customers and Long-Lived Assets [Line Items]
Net external sales	290,515	279,205	834,125	792,859
Europe
Revenues from External Customers and Long-Lived Assets [Line Items]
Net external sales	167,536	151,659	498,379	479,900
Asia Pacific
Revenues from External Customers and Long-Lived Assets [Line Items]
Net external sales	$ 190,626	$ 231,264	$ 576,815	$ 633,938

Fair value measurements - Sched

Fair value measurements - Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) - Recurring - USD ($) $ in Thousands	Jul. 31, 2023	Oct. 31, 2022
Assets:
Foreign currency forward contracts	$ 9,608	$ 5,035
Net investment contracts	3,036
Total assets at fair value	12,644	5,035
Liabilities:
Deferred compensation plans	10,636	9,076
Foreign currency forward contracts	4,209	11,724
Net investment contracts	4,601
Total liabilities at fair value	19,446	20,800
Level 1
Assets:
Foreign currency forward contracts	0	0
Net investment contracts	0
Total assets at fair value	0	0
Liabilities:
Deferred compensation plans	0	0
Foreign currency forward contracts	0	0
Net investment contracts	0
Total liabilities at fair value	0	0
Level 2
Assets:
Foreign currency forward contracts	9,608	5,035
Net investment contracts	3,036
Total assets at fair value	12,644	5,035
Liabilities:
Deferred compensation plans	10,636	9,076
Foreign currency forward contracts	4,209	11,724
Net investment contracts	4,601
Total liabilities at fair value	19,446	20,800
Level 3
Assets:
Foreign currency forward contracts	0	0
Net investment contracts	0
Total assets at fair value	0	0
Liabilities:
Deferred compensation plans	0	0
Foreign currency forward contracts	0	0
Net investment contracts	0
Total liabilities at fair value	$ 0	$ 0

Fair value measurements - Sch_2

Fair value measurements - Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis (Additional Information) (Detail) $ in Millions	9 Months Ended
	Jul. 31, 2023 USD ($)
Fair Value Disclosures [Abstract]
Notional Amounts of foreign currency derivative contracts	$ 385
Executive officers and other highly compensated employees salary and annual cash incentive compensation deferrals percentage, maximum	100%
Executive officers share-based long-term incentive compensation deferrals percentage, maximum	90%

Fair value measurements - Carry

Fair value measurements - Carrying Amounts and Fair Values of Financial Instruments, Other than Cash and Cash Equivalents, Receivables and Accounts Payable (Detail) $ in Thousands	Jul. 31, 2023 USD ($)
Fair Value Disclosures [Abstract]
Long-term debt, carrying amount	$ 838,098
Long-term debt, fair value	$ 836,098

Derivative financial instrume_3

Derivative financial instruments - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2023	Jul. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Maturity of foreign currency forward contracts			90 days
Gains (losses) on foreign currency forward contracts	$ (93)	$ 15,181	$ 12,086	$ 2,503
Change in unrealized gain (loss) on foreign currency derivative instruments	(885)	$ (14,436)	(19,710)	$ (394)
Other Comprehensive Income (Loss), Net Investment Hedge, Net of Tax	$ 1,144		$ (2,467)

Derivative financial instrume_4

Derivative financial instruments - Outstanding Currency, Forward Exchange Contracts (Detail) - USD ($) $ in Thousands	Jul. 31, 2023	Jul. 31, 2022
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	$ 385,000
Foreign Currency Forward Contracts | Notional Sell Amounts
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	146,717	$ 168,410
Foreign Currency Forward Contracts | Notional Sell Amounts | Euro
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	95,064	88,275
Foreign Currency Forward Contracts | Notional Sell Amounts | British pound
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	20,489	36,779
Foreign Currency Forward Contracts | Notional Sell Amounts | Mexican Peso
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	3,227
Foreign Currency Forward Contracts | Notional Sell Amounts | Japanese yen
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	23,195	16,688
Foreign Currency Forward Contracts | Notional Sell Amounts | Hong Kong dollar
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	2,080	0
Foreign Currency Forward Contracts | Notional Sell Amounts | Australian dollar
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	0	278
Foreign Currency Forward Contracts | Notional Sell Amounts | Singapore dollar
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	60	378
Foreign Currency Forward Contracts | Notional Sell Amounts | Taiwan Dollar
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	0
Foreign Currency Forward Contracts | Notional Sell Amounts | Others
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	2,602	26,012
Foreign Currency Forward Contracts | Notional Sell Amounts
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	490,020	642,295
Foreign Currency Forward Contracts | Notional Sell Amounts | Euro
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	194,850	333,285
Foreign Currency Forward Contracts | Notional Sell Amounts | British pound
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	132,956	78,942
Foreign Currency Forward Contracts | Notional Sell Amounts | Mexican Peso
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	28,158
Foreign Currency Forward Contracts | Notional Sell Amounts | Japanese yen
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	17,908	37,163
Foreign Currency Forward Contracts | Notional Sell Amounts | Hong Kong dollar
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	7,265	67,341
Foreign Currency Forward Contracts | Notional Sell Amounts | Australian dollar
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	9,236	9,426
Foreign Currency Forward Contracts | Notional Sell Amounts | Singapore dollar
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	19,817	18,025
Foreign Currency Forward Contracts | Notional Sell Amounts | Taiwan Dollar
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	8,000
Foreign Currency Forward Contracts | Notional Sell Amounts | Others
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	$ 71,830	$ 98,113

Derivative financial instrume_5

Derivative financial instruments - Summary of Fair Values Of Net Investment Contracts (Details)	Jul. 31, 2023 USD ($)
Prepaid expenses and other current assets
Investments, All Other Investments [Abstract]
Net investment contracts	$ 2,977,000
Derivative [Line Items]
Net investment contracts	2,977,000
Other assets
Investments, All Other Investments [Abstract]
Net investment contracts	59,000
Derivative [Line Items]
Net investment contracts	59,000
Accrued liabilities
Investments, All Other Investments [Abstract]
Net investment contracts	841,000
Derivative [Line Items]
Net investment contracts	841,000
Other long-term liabilities
Investments, All Other Investments [Abstract]
Net investment contracts	3,760,000
Derivative [Line Items]
Net investment contracts	$ 3,760,000

Long-term debt - Long-Term Debt

Long-term debt - Long-Term Debt (Detail) - USD ($)	Jul. 31, 2023	Jun. 06, 2023	Oct. 31, 2022	Apr. 30, 2019
Debt Instrument [Line Items]
Long-term debt	$ 846,286,000		$ 738,822,000
Less current maturities and notes payable	110,643,000		392,537,000
Less unamortized debt issuance costs	8,188,000		965,000
Long-term maturities	727,455,000		345,320,000
Revolving credit facility		$ 1,150,000,000
Senior notes, due 2023-2025
Debt Instrument [Line Items]
Senior notes	$ 32,000,000		55,500,000
Weighted average interest rate for borrowings	3.10%
Senior notes, due 2023-2027
Debt Instrument [Line Items]
Senior notes	$ 54,286,000		71,429,000
Weighted average interest rate for borrowings	3.11%
Senior notes, due 2023-2030
Debt Instrument [Line Items]
Senior notes	$ 260,000,000		350,000,000
Weighted average interest rate for borrowings	3.97%
Euro Loan
Debt Instrument [Line Items]
Term loan due 2026	$ 0		261,893,000
Revolving Credit Facility
Debt Instrument [Line Items]
Weighted average interest rate for borrowings	6%
Revolving credit agreement, due 2028 | Maximum
Debt Instrument [Line Items]
Revolver Base Rate Range		0.20%
EuroDollar Base Rate Range		1.20%
Revolving credit agreement, due 2028 | Minimum
Debt Instrument [Line Items]
Revolver Base Rate Range		0%
EuroDollar Base Rate Range		0.85%
Revolving credit agreement, due 2028
Debt Instrument [Line Items]
Revolving credit agreement, due 2024	$ 200,000,000		0
Revolving credit facility		$ 1,150,000,000
Revolving Facility Maximum Borrowing Capacity		850,000,000
Revolving credit agreement, due 2024
Debt Instrument [Line Items]
Revolving credit facility				$ 850,000,000
Term Loan Due 2026
Debt Instrument [Line Items]
Term loan due 2026	$ 300,000,000	$ 300,000,000	$ 0

Long-term debt - Additional Inf

Long-term debt - Additional Information (Detail) € in Thousands	1 Months Ended	9 Months Ended
	Apr. 30, 2019 USD ($)	Jul. 31, 2023 EUR (€)	Jul. 31, 2023 USD ($)	Jun. 06, 2023 USD ($)	Oct. 31, 2022 USD ($)
Debt Instrument [Line Items]
Revolving credit facility				$ 1,150,000,000
Senior notes, due 2023-2025
Debt Instrument [Line Items]
Weighted average interest rate for borrowings		3.10%	3.10%
Remaining weighted average life of notes		1 year 3 months
Senior notes, due 2023-2027
Debt Instrument [Line Items]
Weighted average interest rate for borrowings		3.11%	3.11%
Remaining weighted average life of notes		2 years 2 months 23 days
Senior notes, due 2023-2030
Debt Instrument [Line Items]
Weighted average interest rate for borrowings		3.97%	3.97%
Remaining weighted average life of notes		3 years 1 month 17 days
Euro Loan
Debt Instrument [Line Items]
Term loan due 2026			$ 0		$ 261,893,000
Euro Loan | Euro
Debt Instrument [Line Items]
Euro Loan | €		€ 180,000
Revolving credit agreement, due 2024
Debt Instrument [Line Items]
Revolving credit facility	$ 850,000,000
Credit facility, term	5 years
Revolving credit agreement, due 2024 | Swing Line Loans
Debt Instrument [Line Items]
Revolving credit facility	$ 75,000,000

Contingencies (Details)

Contingencies (Details) - USD ($) $ in Thousands	Jul. 31, 2023	Oct. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Accrual for environmental liability	$ 266	$ 266

Subsequent Events (Details)

Subsequent Events (Details) - EUR (€)		9 Months Ended
	Aug. 24, 2023	Jul. 31, 2023
Subsequent Event [Line Items]
Subsequent Events		Subsequent Event On August 24, 2023, the Company completed the acquisition of the ARAG Group and its subsidiaries (ARAG Group or ARAG) pursuant to the terms of the Sale and Purchase Agreement, dated as of June 25, 2023, by and among the Company, its Italian subsidiary, Capvis Equity V LP (Capvis), DRIP Co-Investment (DRIP), and certain individuals (the Individual Sellers, and together with Capvis and DRIP, collectively, the Sellers). ARAG is a global market and innovation leader in the development, production and supply of precision control systems and smart fluid components for agricultural spraying. ARAG will operate as a division of our Industrial Precision Solutions segment. In anticipation of the acquisition, the Company entered into a €760,000 senior unsecured term loan facility with a group of banks in August 2023 (the Term F acility ). The Term Facility has a 364-day term and matures in August 2024, and loans under the facility bear interest at a eurocurrency rate plus an applicable margin that will range from 1.1250% to 1.625% based on the Company’s Leverage Ratio (as defined in the term loan credit agreement and calculated on a consolidated net debt basis). The all-cash ARAG acquisition of approximately €957,000, net of the repayment of approximately €30,300 of debt of the acquired companies, was funded using the Term Facility and Revolving Facility. The financial results of the ARAG Group acquisition are not expected to have a material impact on our Consolidated Financial Statements.
ARAG Group | Subsequent Event
Subsequent Event [Line Items]
All-cash transaction	€ 957,000,000
Term Loan Facility	760,000,000
Debt Repayment of Acquired Company	€ 30,300,000
ARAG Group | Subsequent Event | Minimum
Subsequent Event [Line Items]
Euro Currency Rate	1.125%
ARAG Group | Subsequent Event | Maximum
Subsequent Event [Line Items]
Euro Currency Rate	1.625%